This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
C3_MALE_GENITAL_EXALLC
No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleonly males |
226837 |
2. Check conditionsNone |
226837 |
3. Check pre-conditions, main-only, mode, registry filtersNone 0 out of 7 registries used, show all original rules. |
0 |
4. Check minimum number of eventsNone |
0 |
5. Include endpoints |
21788 |
6. Filter based on genotype QC (FinnGen only) |
21788 |
Control definitions (FinnGen only)
- Control exclude
- C3_CANCER, C3_CANCER_WIDE_EXALLC
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
based on the number of shared cases.
Similar with more cases:
- Malignant neoplasm, excluding all cancers (controls excluding all cancers)
- Malignant neoplasm, wide definition for exclusion
- Malignant neoplasm, wide definition for exclusion, excluding all cancers (controls excluding all cancers)
Similar with less cases:
Case counts by codes
↥FinnGen case counts by registry codes:
No data for upset plot.
No data for upset table.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 21788 | - | 21788 |
| Unadjusted period prevalence (%) | 9.61 | - | 9.61 |
| Median age at first event (years) | 68.86 | - | 68.86 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4429
- Matched controls
- 37114
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
PJD64
NOMESCO Finland
Laparoscopic dissection of iliac lymph nodes
+∞
323.0
623
*
KC1GB
NOMESCO Finland
Cystography with X-ray
342.5
323.0
377
10
KE1BE
NOMESCO Finland
Rectal ultrasound examinaiton of prostata
6.6
323.0
1213
2008
XKD00
NOMESCO Finland
Uroflowmetry
11.0
323.0
2358
3477
JN4BD
NOMESCO Finland
Extensive body CT
10.6
323.0
897
864
ZXC96
NOMESCO Finland
Robot assisted procedure
235.0
323.0
1083
51
KE3AT
NOMESCO Finland
Transrectal gold marker implantation in prostate under ultrasound guidance
5458.6
323.0
578
*
116
Kela drug reimbursment
Prostate cancer
+∞
323.0
1434
*
R74.8
ICD-10 Finland
Abnormal levels of other serum enzymes
25.0
323.0
1557
788
H02AB02
ATC
dexamethasone; systemic
38.0
323.0
493
122
8140/3-C61.9
ICD-O-3
Adenocarcinoma, NOS, of prostate gland
+∞
323.0
3927
*
WF002
NOMESCO Finland
Radical radiotherapy
830.4
323.0
1117
15
KEC01
NOMESCO Finland
Percutaneous endoscopic radical prostatectomy
+∞
323.0
1678
*
L02BX02
ATC
degarelix; parenteral
+∞
323.0
342
*
Y77
ICPC
Malignant neoplasm prostate
1419.0
323.0
710
5
308
Kela drug reimbursment
Alprostadil, sildenafil and combination product containing aviptadil and phentolamine
154.3
323.0
619
39
L02BB03
ATC
bicalutamide; oral
+∞
323.0
444
*
KE1AT
NOMESCO Finland
Biopsy of prostata with ultrasoudnguidance
70.2
323.0
2279
551
TKE00
NOMESCO Finland
Needle biopsy of prostate
17.6
323.0
566
307
XX3DW
NOMESCO Finland
Time consuming IT work
16.0
323.0
1100
751
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
+∞
323.0
431
*
R86.0
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of enzymes
24.9
323.0
700
278
130
Kela drug reimbursment
Malignant tumour
+∞
323.0
331
*
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
4.6
323.0
2006
5622
L02AE02
ATC
leuprorelin; implant, parenteral
9016.3
323.0
877
*
C61
ICD-10 Finland
Malignant neoplasm of prostate
13890.4
323.0
3893
10
NK6AN
NOMESCO Finland
Total body bone isotope imaging
278.6
323.0
526
18
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
9.8
323.0
1950
2761
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
500.7
316.6
333
6
ZX012
NOMESCO Finland
Radiotherapy with large shaped fields - isocentric therapy
329.3
308.9
330
9
YL1AD
NOMESCO Finland
CT examination of pelvis for dose design of radiotherapy
720.8
307.2
320
*
JN4AD
NOMESCO Finland
Body CT examination
11.4
304.0
623
524
G04BE03
ATC
sildenafil; oral
42.8
300.6
397
85
KFC00
NOMESCO Finland
Unilateral orchiectomy
75.6
296.6
357
43
J01EA01
ATC
trimethoprim; systemic
6.9
292.2
822
1179
KE1DG
NOMESCO Finland
Very extensive MRI of prostate
32.3
290.3
408
116
YJ2VG
NOMESCO Finland
MRI examination of pelvis with high intensity magnet for dose design of radiotherapy
+∞
280.6
285
*
KEC00
NOMESCO Finland
Retropubic radical prostatectomy
+∞
279.6
284
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2467.1
278.2
285
*
A04AA02
ATC
granisetron; systemic, transdermal
370.4
273.4
291
7
WF003
NOMESCO Finland
Adjuvant radiotherapy
506.6
269.7
284
5
ZX070
NOMESCO Finland
Intensity modified radiotherapy
+∞
262.7
267
*
C79.5
ICD-10 Finland
Secondary malignant neoplasm of bone and bone marrow
2287.7
259.3
266
*
G04BE01
ATC
alprostadil; parenteral, urethral
29.3
254.9
367
114
163
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
237.8
242
*
KE1BG
NOMESCO Finland
MRI of prostate
40.6
233.8
312
69
A03FA01
ATC
metoclopramide; systemic, rectal
5.9
231.5
739
1227
KDE20
NOMESCO Finland
Removal of foreign body from urethra
81.2
228.7
273
30
D40.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Testis
46.7
228.6
297
57
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
+∞
219.0
223
*
YX9AD
NOMESCO Finland
Other CT eamination for dose design of radiotherapy
164.8
217.1
242
13
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
376.5
201.6
215
5
D40.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Prostate
27.0
199.4
293
97
C62.11
ICD-10 Finland
Malignant tumor of the descending testicle, seminoma
+∞
197.2
201
*
L02BB04
ATC
enzalutamide; oral
+∞
195.2
199
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.0
193.0
1469
5260
ZX090
NOMESCO Finland
Other technic of radiotherapy
565.0
184.3
194
*
L02AE04
ATC
triptorelin; parenteral
+∞
181.3
185
*
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
24.9
173.8
261
93
KE1CG
NOMESCO Finland
Extensive MRI of prostate
43.7
173.4
228
46
B01AB05
ATC
enoxaparin; parenteral
2.9
173.4
1409
5191
WZC30
NOMESCO Finland
Teaching
3.9
165.0
788
1944
XJH00
NOMESCO Finland
Transanal ultrasonography
5.6
163.2
534
892
KEB00
NOMESCO Finland
Biopsy of prostate
34.1
159.6
221
57
9061/3-C62.9
ICD-O-3
Seminoma, NOS, of testis, NOS
+∞
158.6
162
*
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
3.2
158.2
998
3066
352
Kela drug reimbursment
Abiraterone and enzalutamide
+∞
156.6
160
*
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
1431.2
154.5
160
*
M05BX04
ATC
denosumab; parenteral
21.0
150.7
238
100
G04CA02
ATC
tamsulosin; oral
2.5
150.2
1661
7196
L03AA13
ATC
pegfilgrastim; parenteral
671.4
147.7
155
*
WF029
NOMESCO Finland
Radiotherapy of local residive tumor
+∞
145.8
149
*
TKW99
NOMESCO Finland
Other minor surgical procedure in urology
37.5
145.3
197
46
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
11.4
141.9
287
225
UKC02
NOMESCO Finland
Cystoscopy
3.2
139.6
883
2690
WX402
NOMESCO Finland
General anaesthesia
3.1
139.6
931
2945
C62.12
ICD-10 Finland
Malignant tumor of the descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
135.0
138
*
J01MA02
ATC
ciprofloxacin; systemic
2.3
131.6
1878
9085
ZX080
NOMESCO Finland
Image guided radiotherapy
590.7
130.1
137
*
WF090
NOMESCO Finland
Profylactic radiotherapy
+∞
123.2
126
*
N40
ICD-10 Finland
Hyperplasia of prostate
2.3
123.1
1485
6568
TKE10
NOMESCO Finland
Puncture of prostate
191.3
120.4
133
6
N39.3
ICD-10 Finland
Stress incontinence
86.5
118.2
140
14
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
271.4
115.3
125
*
L02BX03
ATC
abiraterone; oral
+∞
115.3
118
*
WD225
NOMESCO Finland
Demanding therapy of methastized malignancy with hormones
+∞
114.3
117
*
G04BE30
ATC
drugs used in erectile dysfunction - combinations
1023.2
114.3
119
*
WF004
NOMESCO Finland
Palliative radiotherapy
996.7
111.3
116
*
N02BE01
ATC
paracetamol; systemic, rectal
2.4
110.6
3655
24746
OAB42
NOMESCO Finland
Guidance related to known health problem
92.0
108.8
128
12
WD205
NOMESCO Finland
Therapy of methastized malignancy with hormones
+∞
107.4
110
*
L03AA14
ATC
lipegfilgrastim; parenteral
+∞
105.5
108
*
TQW40
NOMESCO Finland
Remowal of suture of skin
3.8
103.5
486
1151
PJD54
NOMESCO Finland
Block dissection of iliac lymph nodes
+∞
101.6
104
*
8090/3-C44.9
ICD-O-3
Basal cell carcinoma, NOS, of skin, NOS
+∞
97.6
100
*
Z03.1
ICD-10 Finland
Observation for suspected malignant neoplasm
12.7
96.6
184
126
Z51.5
ICD-10 Finland
Palliative care
13.3
95.9
179
117
A04AA01
ATC
ondansetron; systemic, rectal
9.9
93.4
201
177
NK6BQ
NOMESCO Finland
Whole body extensive bone SPET with low dose CT
218.8
93.1
102
*
3054
Kela drug reimbursment
NA
+∞
92.7
95
*
L03AA02
ATC
filgrastim; parenteral
102.0
92.0
107
9
1523
Kela drug reimbursment
NA
+∞
91.8
94
*
JN4CD
NOMESCO Finland
Very extensive body CT
8.5
83.5
196
201
JN4LR
NOMESCO Finland
Extensive PET-CT of receptors in whole body
+∞
81.0
83
*
Z51.0
ICD-10 Finland
Radiotherapy session
716.0
80.1
84
*
C62.10
ICD-10 Finland
Malignant tumor of the descending testicle, no histological verification
+∞
78.0
80
*
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
243.0
78.0
85
*
NK6AQ
NOMESCO Finland
Whole body bone SPET with low dose CT
672.5
75.2
79
*
TKC52
NOMESCO Finland
Patient education concerning pelvic floor contraction exercises
174.9
73.9
82
*
C67.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of bladder
+∞
73.1
75
*
C62.19
ICD-10 Finland
Malignant tumor of the descending testicle, other or undetermined histology
+∞
71.2
73
*
N02AX02
ATC
tramadol; systemic, rectal
1.8
68.5
1943
11321
N42.9
ICD-10 Finland
Disorder of prostate, unspecified
6.8
68.0
184
235
WD305
NOMESCO Finland
Simple therapy of methastized malignancy with biomodifiers
210.0
67.4
74
*
PJD44
NOMESCO Finland
Excision of iliac lymph nodes
603.1
67.4
71
*
ZX112
NOMESCO Finland
Subcutaneous
12.2
66.5
128
90
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
+∞
66.3
68
*
ZX020
NOMESCO Finland
HDR radiotherapy within tissue
+∞
65.3
67
*
K62.7
ICD-10 Finland
Radiation proctitis
+∞
65.3
67
*
KFH50
NOMESCO Finland
Insertion of prosthetic replacement for testis
155.4
65.2
73
*
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
+∞
64.3
66
*
9085/3-C62.9
ICD-O-3
Mixed germ cell tumor of testis, NOS
+∞
64.3
66
*
N02AA05
ATC
oxycodone; systemic
2.8
64.0
468
1512
WB223
NOMESCO Finland
Demanding adjuvant hormone therapy of malignancy
+∞
63.4
65
*
JN2CM
NOMESCO Finland
Lower part of abdomen extensive MRI examination with Tesla magnet
36.8
60.7
82
19
B01AB10
ATC
tinzaparin; parenteral
4.1
60.0
255
546
R31
ICD-10 Finland
Unspecified haematuria
2.7
59.7
473
1601
G04BD12
ATC
mirabegron; oral
2.9
57.7
381
1150
A79
ICPC
Malignancy NOS
516.7
57.7
61
*
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
135.9
56.7
64
*
KF8AE
NOMESCO Finland
Ultrasound examination of scrotum
4.2
55.6
227
468
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.7
55.4
1683
9810
C44.31
ICD-10 Finland
Basocellular carcinoma of the skin on another or unspecified part of the face
37.0
54.9
74
17
A04AA55
ATC
palonosetron, combinations; systemic
+∞
54.6
56
*
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
+∞
54.6
56
*
A04AD12
ATC
aprepitant; systemic
473.6
52.9
56
*
ZX050
NOMESCO Finland
Stereotactic radiotherapy
61.5
52.7
65
9
L01BC06
ATC
capecitabine; oral
+∞
52.6
54
*
L02AE03
ATC
goserelin; implant
+∞
52.6
54
*
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
15.4
51.7
90
50
9061/3-C62.1
ICD-O-3
Seminoma, NOS, of descended testis
+∞
51.6
53
*
Y06
ICPC
Prostate symptom/complaint
3.9
51.1
230
518
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
+∞
50.7
52
*
U04
ICPC
Incontinence urine
6.3
50.6
143
194
TKC20
NOMESCO Finland
Catheterisation of bladder
3.0
50.4
318
929
R33
ICD-10 Finland
Retention of urine
2.8
50.0
349
1090
C77.5
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrapelvic lymph nodes
+∞
49.7
51
*
KCC10
NOMESCO Finland
Cystoprostatectomy
430.6
48.0
51
*
PJA12
NOMESCO Finland
Sentinel node biopsy
430.6
48.0
51
*
TPH07
NOMESCO Finland
Cathetrisation of artery
2.4
47.5
435
1586
XX1AD
NOMESCO Finland
Other CT-examination
76.3
45.2
54
6
KCD02
NOMESCO Finland
Transurethral resection of bladder
17.2
45.1
75
37
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
+∞
44.8
46
*
C62.1
ICD-10 Finland
Malignant neoplasm: Descended testis
+∞
44.8
46
*
JN2DM
NOMESCO Finland
Lower part of abdomen very extensive MRI examination with Tesla magnet
52.7
44.5
56
9
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
396.3
44.1
47
*
KD1GB
NOMESCO Finland
Uretrocystogpaphy with X-ray
32.4
44.1
61
16
G03HA01
ATC
cyproterone; systemic
23.4
43.8
66
24
WB221
NOMESCO Finland
Demanding neoadjuvant hormone therapy of malignancy
+∞
43.8
45
*
KDG43
NOMESCO Finland
Transobturatorial sling urethrocystopexy
+∞
43.8
45
*
8120/3-C67.9
ICD-O-3
Transitional cell carcinoma, NOS, of bladder, NOS
+∞
43.8
45
*
KE1DR
NOMESCO Finland
Prostate metabolic PET with CT
+∞
42.8
44
*
C62.99
ICD-10 Finland
Malignant tumor in unspecified location in testis,other or undetermined histology
+∞
42.8
44
*
C62.90
ICD-10 Finland
Malignant tumor in unspecified location in testis, no histological verification
+∞
42.8
44
*
C67.9
ICD-10 Finland
Malignant neoplasm: Bladder, unspecified
379.1
42.2
45
*
JN2BG
NOMESCO Finland
MRI examination of lower part of abdoment with high intensity magnet
28.9
40.9
58
17
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
129.7
40.7
46
*
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
+∞
39.9
41
*
9070/3-C62.9
ICD-O-3
Embryonal carcinoma, NOS, of testis, NOS
+∞
38.9
40
*
C77.8
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of multiple regions
+∞
38.9
40
*
J01MA12
ATC
levofloxacin; systemic
1.9
38.6
706
3439
G04CA01
ATC
alfuzosin; oral
1.8
37.6
840
4369
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
173.2
37.1
41
*
JN3AD
NOMESCO Finland
Abdominal CT examination
2.5
37.0
327
1165
KDW96
NOMESCO Finland
Other operations on urethra
90.9
36.8
43
*
WW500
NOMESCO Finland
Blood transfusion
5.1
36.8
122
203
XKG00
NOMESCO Finland
Artificial induction of erection
26.4
36.5
53
17
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.5
36.3
1662
10436
KCD05
NOMESCO Finland
Excision of bladder lesion during urinary tract endoscopy with photodynamic diagnosis (PDD)
48.6
36.2
46
8
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.9
36.0
157
344
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
+∞
36.0
37
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
2.2
35.3
412
1680
YX9BD
NOMESCO Finland
Other extensive CT eamination for dose design of radiotherapy
164.7
35.2
39
*
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
51.9
34.2
43
7
ZX013
NOMESCO Finland
Radiotherapy with large shaped fields - SSD therapy
156.2
33.2
37
*
A06AH03
ATC
naloxegol; oral
24.4
33.1
49
17
C60.1
ICD-10 Finland
Malignant neoplasm: Glans penis
+∞
33.1
34
*
8090/3-C44.3
ICD-O-3
Basal cell carcinoma, NOS, of skin of other and unspecified parts of face
+∞
33.1
34
*
TKC22
NOMESCO Finland
Catheterisation instruction
4.1
33.0
137
288
XX7FT
NOMESCO Finland
Radioyttrium therapy with connected antibody
293.5
32.6
35
*
C44.51
ICD-10 Finland
Basocellular carcinoma of the skin on the torso
44.4
32.5
42
8
Z12.5
ICD-10 Finland
Special screening examination for neoplasm of prostate
8.5
32.3
74
74
D41.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bladder
11.4
32.1
63
47
WB203
NOMESCO Finland
Simple adjuvant hormone therapy of malignancy
+∞
32.1
33
*
PJD53
NOMESCO Finland
Block dissection of aortic lymph nodes
+∞
32.1
33
*
G04BD08
ATC
solifenacin; oral
3.0
32.1
199
574
WVA20
NOMESCO Finland
Medicine administration
4.3
31.5
124
248
G04BE09
ATC
vardenafil; oral
54.8
31.3
39
6
C67.2
ICD-10 Finland
Malignant neoplasm: Lateral wall of bladder
+∞
31.1
32
*
2BX02
NOMESCO Finland
NA
+∞
31.1
32
*
C62.92
ICD-10 Finland
Malignant tumor in unspecified location in testis, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
31.1
32
*
D70.82
ICD-10 Finland
Drug-induced neutropenia
15.5
30.9
53
29
R74.9
ICD-10 Finland
Abnormal level of unspecified serum enzyme
12.5
29.9
56
38
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
6.2
29.6
84
116
C62.00
ICD-10 Finland
Malignant tumor of the non-descending testicle, no histological verification
+∞
29.2
30
*
8090/3-C44.5
ICD-O-3
Basal cell carcinoma, NOS, of skin of trunk
+∞
29.2
30
*
TPH04
NOMESCO Finland
Cathetrisation of vein
1.7
28.8
742
3988
KH1BT
NOMESCO Finland
Urinary tract cathetrisation with X-ray guidance
12.4
28.7
54
37
Z08.1
ICD-10 Finland
Follow-up examination after radiotherapy for malignant neoplasm
263.5
28.7
31
*
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
5.7
28.5
86
129
C83.31
ICD-10 Finland
Diffuse lymphoma with large B cells
+∞
28.2
29
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
3.5
27.9
139
342
ZXC20
NOMESCO Finland
Use of chemical agents
8.9
27.5
61
58
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
27.4
316
1277
C62.91
ICD-10 Finland
Malignant tumor in unspecified location in testis, seminoma
+∞
27.2
28
*
8310/3-C64.9
ICD-O-3
Clear cell adenocarcinoma, NOS, of kidney, NOS
+∞
27.2
28
*
R86.1
ICD-10 Finland
Abnormal findings in specimens from male genital organs, abnormal level of hormones
9.9
27.2
57
49
KED22
NOMESCO Finland
Transurethral resection of prostate
2.5
26.6
227
792
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
+∞
26.3
27
*
YN7BD
NOMESCO Finland
Extensive CT examination of spine for dose design of radiotherapy
+∞
26.3
27
*
C62.02
ICD-10 Finland
Malignant tumor of the non-descending testicle, embryonic carsinoma, teratocarcinoma or coriocarsinoma
+∞
26.3
27
*
7511
FHL
Orchidectomy (unilateral), also includes funicularectomy
26.0
25.6
37
12
WX704
NOMESCO Finland
Intubation
2.2
25.1
272
1068
C62.01
ICD-10 Finland
Malignant tumor of the non-descending testicle, seminoma
+∞
24.3
25
*
YN7AD
NOMESCO Finland
CT examination of spine for dose design of radiotherapy
+∞
24.3
25
*
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
113.7
23.8
27
*
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.2
23.8
254
994
WF099
NOMESCO Finland
Other radiotherapy
21.7
23.7
36
14
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
+∞
23.4
24
*
9085/3-C62.1
ICD-O-3
Mixed germ cell tumor of descended testis
+∞
23.4
24
*
Y78
ICPC
Malign neopl male genital other
+∞
23.4
24
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
+∞
23.4
24
*
YG1BD
NOMESCO Finland
Extensive CT examination of thorax for dose design of radiotherapy
+∞
23.4
24
*
XX9AQ
NOMESCO Finland
Supplementary SPECT-CT or additional scan
109.5
22.8
26
*
ZX022
NOMESCO Finland
LDR radiotherapy within tissue
+∞
22.4
23
*
1CD02
NOMESCO Finland
NA
+∞
22.4
23
*
KE002
NOMESCO Finland
Radical radiotherapy of prostata and seminal vesicles
+∞
22.4
23
*
XKD03
NOMESCO Finland
Urethral pressure profilometry
5.0
22.3
74
125
WX725
NOMESCO Finland
Noninvasive ventilation
2.4
22.2
195
693
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.9
22.0
358
1658
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
202.0
22.0
24
*
WX110
NOMESCO Finland
Local anesthesy
1.4
21.8
2646
19293
18699
ICD-8 Finland
Malignant neoplasm of testis
+∞
21.4
22
*
C62
ICD-10 Finland
Malignant neoplasm of testis
+∞
21.4
22
*
XKW99
NOMESCO Finland
Other physiological examination of urinary or male genital system
4.9
21.1
71
122
KE1DM
NOMESCO Finland
Very extensive MRI of prostate (more than 1.5 T)
70.2
21.0
25
*
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.6
20.7
602
3318
XX3AT
NOMESCO Finland
Other labeling with ultrasound guidance
21.8
20.6
31
12
C62.9
ICD-10 Finland
Malignant neoplasm: Testis, unspecified
+∞
20.4
21
*
KH1FT
NOMESCO Finland
Exchange of urinary catheter with radiological guidance
29.5
20.1
28
8
R4110
NOMESCO Finland
Physiotherapy
1.5
20.0
914
5584
D41.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Kidney
4.7
20.0
70
126
WVA30
NOMESCO Finland
Intramuscular and subcutaneous injection
16.4
19.9
33
17
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.1
19.8
112
304
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
+∞
19.5
20
*
9081/3-C62.9
ICD-O-3
Teratocarcinoma of testis, NOS
+∞
19.5
20
*
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
8.3
19.3
44
45
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
2.6
19.1
143
466
YA1BD
NOMESCO Finland
Extensive CT examination of head and neck for dose design of radiotherapy
92.6
19.1
22
*
KDV12
NOMESCO Finland
Urethroscopic internal urethrotomy
5.2
19.0
61
100
8140/3-C18.7
ICD-O-3
Adenocarcinoma, NOS, of sigmoid colon
+∞
18.5
19
*
C60.9
ICD-10 Finland
Malignant neoplasm: Penis, unspecified
+∞
18.5
19
*
N30.4
ICD-10 Finland
Irradiation cystitis
+∞
18.5
19
*
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
88.4
18.1
21
*
JN6AD
NOMESCO Finland
CT of torso and neck
8.9
17.9
39
37
R50.9
ICD-10 Finland
Fever, unspecified
1.7
17.9
415
2150
117
Kela drug reimbursment
Leukaemia and other malignant diseases of the blood and bone marrow, and malignant diseases of the lymphatic tissue
4.1
17.8
71
146
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
+∞
17.5
18
*
KBJ60
NOMESCO Finland
Anastomosis of ureter to urethra with interposition of ileum
+∞
17.5
18
*
C77.0
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph nodes of head, face and neck
+∞
17.5
18
*
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
59.0
17.3
21
*
N99.1
ICD-10 Finland
Postprocedural urethral stricture
10.6
17.2
34
27
KE1AE
NOMESCO Finland
Percutaneous utlrasound examination fo prostata
8.2
17.1
39
40
WX320
NOMESCO Finland
Spinalanesthesy
1.5
16.7
724
4363
ZX095
NOMESCO Finland
Combined chemoradiotherapy
+∞
16.5
17
*
C60.0
ICD-10 Finland
Malignant neoplasm: Prepuce
+∞
16.5
17
*
C79.30
ICD-10 Finland
Secondary malignant tumor of the cerebrum
+∞
16.5
17
*
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
+∞
16.5
17
*
R39.1
ICD-10 Finland
Other difficulties with micturition
2.3
16.3
150
547
YG1AD
NOMESCO Finland
CT examination of thorax for dose design of radiotherapy
151.3
16.3
18
*
KA1FN
NOMESCO Finland
Isotope renography
7.5
16.2
39
44
M87.1
ICD-10 Finland
Osteonecrosis due to drugs
22.4
16.2
24
9
QAE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin in head or neck
2.3
16.1
160
607
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.8
15.9
103
310
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.0
15.8
209
896
TJF80
NOMESCO Finland
Ostomy education
12.2
15.7
29
20
ZX120
NOMESCO Finland
Intravenous
1.9
15.6
243
1107
8070/3-C60.1
ICD-O-3
Squamous cell carcinoma, NOS, of glans penis
+∞
15.6
16
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
+∞
15.6
16
*
XX1XQ
NOMESCO Finland
Other SPECT-CT
+∞
15.6
16
*
C73.91
ICD-10 Finland
Papillary carcinoma of the thyroid gland (thyroid gland)
+∞
15.6
16
*
OAB77
NOMESCO Finland
Discussion on exercise habits and instruction concerning use of sports and fitness services
+∞
15.6
16
*
K52.0
ICD-10 Finland
Gastroenteritis and colitis due to radiation
26.4
15.5
22
7
PJ2AT
NOMESCO Finland
Biopsy of lymphnode with ultrasound guidance
26.4
15.5
22
7
NK6SN
NOMESCO Finland
Bone SPECT
75.7
15.3
18
*
FN1AC
NOMESCO Finland
Angiography of heart and/or coronary arteries
0.7
15.0
544
6255
N45.9
ICD-10 Finland
Orchitis, epididymitis and epididymo-orchitis without abscess
2.4
14.8
129
458
C77.4
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Inguinal and lower limb lymph nodes
+∞
14.6
15
*
8070/3-C60.9
ICD-O-3
Squamous cell carcinoma, NOS, of penis, NOS
+∞
14.6
15
*
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
134.5
14.4
16
*
YA1AD
NOMESCO Finland
CT examination of head and neck for dose design of radiotherapy
28.0
14.4
20
6
XKD06
NOMESCO Finland
Physiologic investigation of micturition
2.4
14.0
118
412
JN4JR
NOMESCO Finland
Whole body extensive metabolic PET with CT
8.4
14.0
31
31
121
Kela drug reimbursment
Severe hypofunction of sexual glands
4.2
13.9
53
106
XKC03
NOMESCO Finland
Water cystometry
2.9
13.8
85
248
KA3EB
NOMESCO Finland
Antegrade pyelography
8.7
13.8
30
29
ZX100
NOMESCO Finland
Oral
4.4
13.7
50
96
D29.2
ICD-10 Finland
Benign neoplasm: Testis
14.9
13.6
23
13
C43.52
ICD-10 Finland
Malignant melanoma on the torso: 'superficial spreading' type
47.6
13.6
17
*
Z85.4
ICD-10 Finland
Personal history of malignant neoplasm of genital organs
+∞
13.6
14
*
M49.5*C79.5
ICD-10 Finland
Metastatic fracture of vertebra
+∞
13.6
14
*
C77.9
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Lymph node, unspecified
126.0
13.4
15
*
PJD55
NOMESCO Finland
Block dissection of inguinal lymph nodes
126.0
13.4
15
*
SPAT1262
SPAT
Handing over of treatment supplies
1.4
13.1
676
4195
JN2DG
NOMESCO Finland
Very extensive MRI examination of lower part of abdoment with high intensity magnet
11.9
13.0
24
17
8130/2-C67.9
ICD-O-3
Papillary urothelial carcinoma, non-invasive of bladder, NOS
+∞
12.6
13
*
C61, D400
ICD-10 Finland
NA
+∞
12.6
13
*
U76
ICPC
Malignant neoplasm of bladder
+∞
12.6
13
*
KE2KT
NOMESCO Finland
Marker implantation in prostate under radiological guidance
+∞
12.6
13
*
PJ5AN
NOMESCO Finland
Localisation of sentinell lymphnode with isotope imaging
+∞
12.6
13
*
C25.0
ICD-10 Finland
Malignant neoplasm: Head of pancreas
+∞
12.6
13
*
1869B
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROT),CA EMBR/TERATOCA/CHORIOCA]
+∞
12.6
13
*
8720/3-C44.9
ICD-O-3
Malignant melanoma, NOS, of skin, NOS
+∞
12.6
13
*
C34.12
ICD-10 Finland
Malignant tumor of the anterior, bronchial or pulmonary adenocarcinoma
117.6
12.5
14
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.5
12.4
393
2205
UKC05
NOMESCO Finland
Cystoscopy and bladder biopsy
5.3
12.3
38
61
R86.9
ICD-10 Finland
Abnormal findings in specimens from male genital organs, unspecified abnormal finding
13.6
12.1
21
13
WX600
NOMESCO Finland
Single shot through catheter
7.2
11.9
29
34
WVA30
SPAT
NA
2.2
11.8
117
447
8720/3-C44.5
ICD-O-3
Malignant melanoma, NOS, of skin of trunk
+∞
11.7
12
*
JN4ED
NOMESCO Finland
Body CT examination with specail preparation
+∞
11.7
12
*
KE2JT
NOMESCO Finland
Demanding radiation source placement in prostate under ultrasound guidance
+∞
11.7
12
*
8097/3-C44.9
ICD-O-3
Basal cell carcinoma, nodular of skin, NOS
+∞
11.7
12
*
XX7AT
NOMESCO Finland
Radiation therapy with Radium-223
+∞
11.7
12
*
KGC00
NOMESCO Finland
Partial amputation of penis
+∞
11.7
12
*
U77
ICPC
Malignant neopl urinary tract other
+∞
11.7
12
*
D07.5
ICD-10 Finland
Carcinoma in situ: Prostate
+∞
11.7
12
*
KAD01
NOMESCO Finland
Percutaneous endoscopic partial nephrectomy
14.0
11.7
20
12
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
11.6
112
1737
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
11.5
277
1451
KWD00
NOMESCO Finland
Reoperation for superficial haemorrhage in urological surgery
11.8
11.4
21
15
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
1.8
11.3
214
1042
KAC11
NOMESCO Finland
Total nephrectomy with capsule, transcutaneous
14.5
11.3
19
11
OAB75
NOMESCO Finland
Nutritional guidance related to maintaining health
31.5
11.2
15
*
KCW96
NOMESCO Finland
Other operations on bladder
8.1
11.1
25
26
G04CB02
ATC
dutasteride; oral
1.7
11.1
256
1324
ZX136
NOMESCO Finland
Intravesicalis
11.0
11.1
21
16
KCW02
NOMESCO Finland
Lavation of bladder for coagulated blood
5.0
11.0
35
59
GDC01
NOMESCO Finland
Thoracoscopic lobectomy of lung
22.4
11.0
16
6
N35.9
ICD-10 Finland
Urethral stricture, unspecified
3.0
10.8
63
179
WF001
NOMESCO Finland
Preoperative radiotherapy
54.5
10.7
13
*
KDK10
NOMESCO Finland
Implantation of artificial urinary sphincter around bulbar urethra
+∞
10.7
11
*
9080/3-C62.9
ICD-O-3
Teratoma, malignant, NOS, of testis, NOS
+∞
10.7
11
*
YN1AD
NOMESCO Finland
CT examination of extremities for dose design of radiotherapy
+∞
10.7
11
*
WB201
NOMESCO Finland
Simple neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
8312/3-C64.9
ICD-O-3
Renal cell carcinoma, NOS, of kidney, NOS
+∞
10.7
11
*
C85.9
ICD-10 Finland
Non-Hodgkin lymphoma, unspecified
+∞
10.7
11
*
1869A
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),SEMINOMA]
+∞
10.7
11
*
8260/3-C73.9
ICD-O-3
Papillary adenocarcinoma, NOS, of thyroid gland
+∞
10.7
11
*
WB211
NOMESCO Finland
Neoadjuvant hormone therapy of malignancy
+∞
10.7
11
*
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
100.8
10.6
12
*
C90.0
ICD-10 Finland
Multiple myeloma
100.8
10.6
12
*
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
2.6
10.4
76
248
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
10.3
348
1979
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
10.2
14
483
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
2.6
10.2
75
246
U08
ICPC
Urinary retention
2.7
10.1
68
213
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
10.1
3795
30347
TQX05
NOMESCO Finland
Skin puncture, unspecified location
10.6
9.9
19
15
A02BC02
ATC
pantoprazole; systemic
1.2
9.9
2236
16830
9680/3-C62.9
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of testis, NOS
+∞
9.7
10
*
C67
ICD-10 Finland
Malignant neoplasm of bladder
+∞
9.7
10
*
L02BB01
ATC
flutamide; oral
+∞
9.7
10
*
PJ5AQ
NOMESCO Finland
Sentinell lymphnode SPECT with low dose CT
+∞
9.7
10
*
Z08.8
ICD-10 Finland
Follow-up examination after other treatment for malignant neoplasm
92.4
9.7
11
*
WW300
NOMESCO Finland
Transfer of autologic stem cells
92.4
9.7
11
*
SPAT1153
SPAT
Removal of sutures
1.3
9.7
1009
6948
JN6BD
NOMESCO Finland
Extensive CT of torso and neck
5.2
9.5
29
47
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.5
9.5
71
236
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.8
9.2
162
775
U06
ICPC
Haematuria
2.6
9.2
67
220
WW200
SPAT
NA
0.6
9.2
194
2482
E89.5
ICD-10 Finland
Postprocedural testicular hypofunction
33.6
9.1
12
*
KE2AT
NOMESCO Finland
Cytologoy of prostata with ultrasound guidance
33.6
9.1
12
*
N39.4
ICD-10 Finland
Other specified urinary incontinence
2.5
9.0
71
242
N05AX08
ATC
risperidone; systemic
0.5
9.0
72
1178
Z94.8
ICD-10 Finland
Other transplanted organ and tissue status
8.0
9.0
20
21
P72
ICPC
Schizophrenia
0.2
8.9
12
417
KGD00
NOMESCO Finland
Partial excision of glans penis
46.2
8.9
11
*
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
8.9
18
505
TKC10
NOMESCO Finland
Percutaneous puncture of bladder
3.8
8.8
37
83
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.6
8.8
39
92
ZX137
NOMESCO Finland
To penis
+∞
8.8
9
*
D63.0
ICD-10 Finland
Anaemia in neoplastic disease
+∞
8.8
9
*
8720/3-C44.6
ICD-O-3
Malignant melanoma, NOS, of skin of upper limb and shoulder
+∞
8.8
9
*
C92.0
ICD-10 Finland
Acute myeloblastic leukaemia [AML]
+∞
8.8
9
*
C62.09
ICD-10 Finland
Malignant tumor of the non-descending testicle, other or undetermined histology
+∞
8.8
9
*
PJD71
NOMESCO Finland
Extended sparing excision of cervical lymph nodes
+∞
8.8
9
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
+∞
8.8
9
*
C43.62
ICD-10 Finland
Malignant melanoma of upper extremity including shoulder: 'superficial spreading' type
+∞
8.8
9
*
C43.59
ICD-10 Finland
Malignant melanoma of the trunk other or unspecified histology
+∞
8.8
9
*
C15.5
ICD-10 Finland
Malignant neoplasm: Lower third of oesophagus
+∞
8.8
9
*
9070/3-C62.1
ICD-O-3
Embryonal carcinoma, NOS, of descended testis
+∞
8.8
9
*
WD215
NOMESCO Finland
Multiple therapy of methastized malignancy with hormones
+∞
8.8
9
*
OAA41
NOMESCO Finland
Health check based on individual needs
83.9
8.7
10
*
KGD05
NOMESCO Finland
Partial excision of body of penis
83.9
8.7
10
*
U99
ICPC
Urinary disease other
5.5
8.7
25
38
R93.4
ICD-10 Finland
Abnormal findings on diagnostic imaging of urinary organs
5.2
8.6
26
42
A50
ICPC
General and Unspecified, Medication/prescr/renewal
2.1
8.6
99
405
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.0
8.5
48
134
C44.41
ICD-10 Finland
Basocellular carcinoma of the skin of the scalp and neck
18.2
8.5
13
6
YX8BD
NOMESCO Finland
Stereotactic extensive CT examination for dose design of radiotherapy
18.2
8.5
13
6
PJ3AT
NOMESCO Finland
Cytology of lymphnode with ultrasound guidance
9.5
8.5
17
15
XX1ZW
NOMESCO Finland
Very extensive written report from radiologist
5.6
8.5
24
36
103
Kela drug reimbursment
Diabetes, insulin-treated
0.8
8.5
733
7504
N30.9
ICD-10 Finland
Cystitis, unspecified
2.5
8.4
64
215
N42.8
ICD-10 Finland
Other specified disorders of prostate
4.3
8.3
30
59
WD325
NOMESCO Finland
Demanding therapy of methastized malignancy with biomodifiers
13.1
8.1
14
9
N05AA02
ATC
levomepromazine; systemic
0.5
8.1
60
1004
PJD45
NOMESCO Finland
Excision of inguinal lymph nodes
9.6
8.0
16
14
B01AB04
ATC
dalteparin; parenteral
2.0
8.0
102
438
N48.4
ICD-10 Finland
Impotence of organic origin
1.8
8.0
142
683
4194
NOMESCO Finland
NA
42.0
8.0
10
*
UJF32
NOMESCO Finland
Coloscopy
1.3
8.0
697
4678
NA7DG
NOMESCO Finland
Spine and spinal cord very extensive MRI examination with high intensity magnet
3.5
8.0
36
87
XW3AT
NOMESCO Finland
Biopsy of other superficial organ with ultrasound guidance
7.6
7.9
18
20
I25.1
ICD-10 Finland
Atherosclerotic heart disease
0.8
7.9
470
5046
5703
FHL
Removal of lymph nodes from the retroperitoneal space
75.6
7.8
9
*
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
+∞
7.8
8
*
HA013
NOMESCO Finland
Radiotherapy after total ablation of mammary gland
+∞
7.8
8
*
C77.1
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intrathoracic lymph nodes
+∞
7.8
8
*
C34.10
ICD-10 Finland
Malignant tumor of the upper lobe, bronchus or lung without histology
+∞
7.8
8
*
C62.0
ICD-10 Finland
Malignant neoplasm: Undescended testis
+∞
7.8
8
*
PJD99
NOMESCO Finland
Excision of other lymph nodes
+∞
7.8
8
*
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
+∞
7.8
8
*
C22.0
ICD-10 Finland
Malignant neoplasm: Liver cell carcinoma
+∞
7.8
8
*
1869X
ICD-9 Finland
Malignant neoplasm of testis, Other and unspecified testis[NEOPL MAL TESTIS (SCROTALIS),EI HIST VAHV]
+∞
7.8
8
*
KCC20
NOMESCO Finland
Cystoprostatourethrectomy
+∞
7.8
8
*
5BX04
NOMESCO Finland
NA
+∞
7.8
8
*
8070/3-C44.9
ICD-O-3
Squamous cell carcinoma, NOS, of skin, NOS
+∞
7.8
8
*
C67.0
ICD-10 Finland
Malignant neoplasm: Trigone of bladder
+∞
7.8
8
*
A10AB01
ATC
insulin (human); parenteral (insulins and analog. for injection, fast-acting)
0.4
7.8
31
643
YJ1AD
NOMESCO Finland
CT examination of abdomen for dose design of radiotherapy
23.1
7.7
11
*
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
23.1
7.7
11
*
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.2
7.7
1405
10262
A10AA02
ATC
NA
0.4
7.6
24
550
N41.0
ICD-10 Finland
Acute prostatitis
1.8
7.6
127
598
A41.5
ICD-10 Finland
Sepsis due to other Gram-negative organisms
2.3
7.5
68
252
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.3
7.5
509
3291
J01CA08
ATC
pivmecillinam; oral
1.9
7.5
112
510
JN2BD
NOMESCO Finland
Extensive CT exmaniation of lower part of abdomen
7.5
7.5
17
19
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
6.9
7.5
18
22
N05AC02
ATC
thioridazine; oral
0.3
7.4
13
393
WW409
NOMESCO Finland
Other aferesis
28.0
7.4
10
*
KBV15
NOMESCO Finland
Cystoscopic change of ureteral stent
5.1
7.3
22
36
KGB00
NOMESCO Finland
Biopsy of penis
6.1
7.3
19
26
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.1
7.3
38
103
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
7.1
7.2
17
20
EP1AE
NOMESCO Finland
Neck ultrasound examination
1.9
7.1
99
440
N30.0
ICD-10 Finland
Acute cystitis
1.8
7.1
125
599
KFC10
NOMESCO Finland
Bilateral orchiectomy
37.7
7.1
9
*
C44.61
ICD-10 Finland
Basocellular carcinoma of the skin of the upper extremity including the shoulder
37.7
7.1
9
*
D40.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other male genital organs
7.5
7.0
16
18
215
Kela drug reimbursment
Diabetes, non-insulin-treated
0.8
7.0
725
7299
E10.7
ICD-10 Finland
Type 1 diabetes mellitus, With multiple complications
0.4
7.0
22
501
N05AH02
ATC
clozapine; systemic
0.3
6.9
15
405
D38.1
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Trachea, bronchus and lung
2.9
6.9
41
121
A10AC01
ATC
insulin (human); parenteral (insulins and analog. for injection, intermediate-acting)
0.6
6.9
85
1229
KH1AD
NOMESCO Finland
CT of urinary organs
1.7
6.9
137
684
N13.8
ICD-10 Finland
Other obstructive and reflux uropathy
21.0
6.9
10
*
XW000
NOMESCO Finland
Bone marrow biopsy
2.1
6.9
76
310
N03AG01
ATC
valproic acid; systemic, rectal
0.6
6.9
76
1131
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.5
6.8
221
1250
8090/3-C44.6
ICD-O-3
Basal cell carcinoma, NOS, of skin of upper limb and shoulder
+∞
6.8
7
*
C34.32
ICD-10 Finland
Malignant tumor of the lower lobe, bronchus or lung adenocarcinoma
+∞
6.8
7
*
8260/3-C64.9
ICD-O-3
Papillary adenocarcinoma, NOS, of kidney, NOS
+∞
6.8
7
*
L01CB01
ATC
etoposide; systemic
+∞
6.8
7
*
KDK40
NOMESCO Finland
Removal of artificial urethral sphincter
+∞
6.8
7
*
C81.9
ICD-10 Finland
Hodgkin lymphoma, unspecified
+∞
6.8
7
*
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
+∞
6.8
7
*
C19
ICD-10 Finland
Malignant neoplasm of rectosigmoid junction
+∞
6.8
7
*
C18.72
ICD-10 Finland
Malignant tumor of sigmoid carcinoma of adenoma
+∞
6.8
7
*
Y77
ICD-10 Finland
Ophthalmic devices associated with adverse incidents
+∞
6.8
7
*
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
+∞
6.8
7
*
C83.1
ICD-10 Finland
Mantle cell lymphoma
+∞
6.8
7
*
WC125
NOMESCO Finland
Demanding cytostatic therapy of local tumor recidive
+∞
6.8
7
*
8000/3-C61.9
ICD-O-3
Neoplasm, malignant of prostate gland
+∞
6.8
7
*
E10.9
ICD-10 Finland
Type 1 diabetes mellitus, Without complications
0.5
6.8
52
858
ECB20
NOMESCO Finland
Oral alveoplasty
2.9
6.8
40
118
B01AC04
ATC
clopidogrel; oral
0.7
6.8
324
3592
N04AA02
ATC
biperiden; systemic
0.3
6.8
17
430
T81.9
ICD-10 Finland
Unspecified complication of procedure
2.5
6.7
51
174
D48.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Skin
1.8
6.7
108
505
KDV10
NOMESCO Finland
Internal urethrotomy
3.1
6.7
35
96
KAC10
NOMESCO Finland
Total nephrectomy with capsule
8.4
6.6
14
14
I89.0
ICD-10 Finland
Lymphoedema, not elsewhere classified
5.3
6.6
19
30
KH1BD
NOMESCO Finland
Extensive urinary tract CT examination
3.0
6.6
35
97
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
2.1
6.6
68
268
C91.1
ICD-10 Finland
Chronic lymphocytic leukaemia of B-cell type
25.2
6.5
9
*
QBE10
NOMESCO Finland
Excision of other lesion extending through all layers of skin of trunk
1.6
6.5
153
800
A10AA01
ATC
NA
0.4
6.5
22
488
G04BE08
ATC
tadalafil; oral
9.1
6.5
13
12
KCD32
NOMESCO Finland
Cystoscopic destruction of tumour of bladder
6.0
6.5
17
24
KFA00
NOMESCO Finland
Exploration of testis
4.4
6.4
22
42
D48.0
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Bone and articular cartilage
2.8
6.4
41
125
G04CA52
ATC
tamsulosin and dutasteride; systemic
1.3
6.4
402
2573
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.4
6.4
296
1801
A10AB04
ATC
insulin lispro; parenteral (insulins and analog. for injection, fast-acting)
0.4
6.4
31
597
WX400
NOMESCO Finland
Inhalation anesthesy
1.8
6.3
111
536
C05AA08
ATC
fluocortolone; rectal, topical
1.3
6.3
461
3014
JFF23
NOMESCO Finland
Transversostomy
6.1
6.2
16
22
KWW96
NOMESCO Finland
Other reoperation in urological surgery
33.5
6.2
8
*
U28
ICPC
Limited function/disability (U)
3.4
6.2
28
69
UKD02
NOMESCO Finland
Urethroscopy
4.2
6.2
22
44
FXA00
NOMESCO Finland
Total cardiopulmonary bypass in normothermia or moderate hypothermia at concurrent surgical procedure
0.6
6.1
71
1042
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
1.7
6.1
121
606
J01MA01
ATC
ofloxacin; systemic
1.4
6.1
251
1495
ZXF99
NOMESCO Finland
Other r3eason to interrupt procedure
5.0
6.0
18
30
E10.3
ICD-10 Finland
Type 1 diabetes mellitus, With ophthalmic complications
0.4
6.0
24
496
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
2.1
6.0
64
256
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
4674
14847
2.33
307.65
3.0
2.5
2.6
2.7
e6/l
0.50
4186
12911
6781
24260
2.27
307.65
4.6
3.5
82.5
95.0
e6/l
0.46
5579
17874
594
492
7.63
307.65
2.3
1.3
23.1
19.6
ug/l
0.56
581
480
6502
21697
2.45
307.65
4.1
3.1
136.3
112.7
e6/l
0.32
5420
16782
11784
51974
2.69
307.65
9.9
5.7
81.9
75.9
u/l
16.74
11388
48380
5837
19715
2.31
307.65
3.9
3.0
0.3
0.5
e6/l
5.77
4740
14780
7621
29874
2.11
307.65
4.4
3.8
—
—
—
0
0
7530
25841
2.54
307.65
4.0
3.2
—
0.7
—
0
8
4289
8876
3.71
307.65
2.3
2.2
8.4
15.0
nmol/l
307.65
3710
7886
12648
57108
3.06
307.65
11.7
3.8
9.4
2.2
ug/l
25.40
11306
51570
8143
32127
2.17
307.65
4.8
2.7
1.0
0.7
ug/l
43.28
6429
21596
5232
18791
2.06
307.65
4.6
2.1
2.3
2.3
mmol/l
5.71
4683
15791
8224
33814
2.05
307.65
7.8
4.2
11.6
13.5
umol/l
35.18
7917
31912
10345
45651
2.19
307.65
7.9
3.7
15.3
24.0
%
307.65
7239
21690
10951
41512
3.16
307.65
5.2
3.7
279.7
589.7
e6/l
0.74
214
782
1665
3605
3.04
306.58
4.0
1.6
22.9
8.7
ug/l
1.54
1370
2736
406
201
12.64
306.40
8.8
1.1
1534.8
2.2
u/l
0.53
132
25
3588
11418
2.20
303.97
3.8
2.7
0.6
0.8
e6/l
3.09
2260
6371
3620
12369
2.03
248.51
3.5
2.6
0.8
0.9
e6/l
2.40
2281
7264
391
277
8.82
239.34
2.8
1.7
6.4
5.3
nmol/l
0.25
385
268
7377
32878
1.72
209.19
8.2
6.6
1.2
1.2
mmol/l
2.06
6128
27748
7846
36132
1.67
189.85
9.7
6.5
4.3
4.5
e9/l
8.00
6870
30957
6750
29926
1.68
187.98
7.1
6.3
1.2
1.2
mmol/l
4.56
6138
26824
2412
7788
2.06
186.60
5.0
2.8
252.1
241.1
u/l
1.84
2312
7256
510
675
4.74
181.48
6.6
2.2
471.3
979.1
u/ml
0.21
499
661
6408
28472
1.64
171.88
5.3
4.3
34.7
35.2
g/l
10.80
5934
26199
3905
15174
1.77
171.28
2.6
2.3
—
—
—
0
0
8858
43274
1.60
154.79
5.0
5.0
6.9
7.0
mmol/l
10.73
8426
40659
6915
32195
1.57
144.24
10.3
11.2
1.3
1.4
inr
4.74
2070
8794
193
109
10.93
135.63
9.4
1.2
—
—
—
0
0
1425
4296
2.13
128.54
3.7
2.6
0.2
0.3
e6/l
2.48
1405
4231
2712
10374
1.72
119.48
3.7
2.0
2.5
2.4
mmol/l
15.64
2391
8756
6772
33002
1.45
99.58
3.9
3.3
0.0
0.0
estimate
2.50
1521
5356
6679
32541
1.45
97.65
5.0
4.3
0.0
0.0
estimate
0.50
1593
5827
6693
32742
1.44
94.74
3.8
3.2
0.0
0.0
estimate
0.31
1554
5603
12068
66199
1.54
92.62
19.6
13.1
76.1
77.5
ml/min/173m2
11.68
10664
54148
576
1337
2.69
91.01
3.1
2.0
875.4
107.6
u/ml
1.96
485
1107
12453
68922
1.56
89.70
18.5
14.2
29.6
27.2
mg/l
10.31
10468
54866
13137
73992
1.60
81.40
21.6
17.4
139.6
139.8
mmol/l
16.70
12864
72078
2568
10634
1.57
79.29
3.5
3.0
0.8
0.8
mmol/l
3.58
2441
9834
3776
17001
1.47
78.82
4.2
4.0
85.6
81.7
%
16.91
3710
16612
13151
74204
1.59
78.79
21.9
17.4
4.0
4.0
mmol/l
4.72
12861
72212
1908
7391
1.66
77.06
3.7
3.4
—
—
—
0
0
5305
25650
1.40
74.25
4.1
3.4
—
—
—
0
0
1401
5160
1.72
67.63
5.1
3.4
1.2
1.2
mmol/l
1.73
1233
4450
6224
31320
1.36
65.86
5.8
5.8
24.6
26.1
%
17.34
5747
28944
3763
17479
1.42
64.09
2.1
2.2
3.0
2.9
mg/l
1.22
3187
14781
6046
30405
1.35
63.46
5.6
5.7
2.9
3.0
%
3.26
5607
28174
3901
18293
1.41
62.69
4.1
3.6
0.0
0.0
estimate
0.21
1443
5353
13162
75121
1.51
60.60
24.3
16.6
91.0
89.4
umol/l
3.82
13157
75087
6077
30899
1.33
57.35
5.5
5.7
59.6
58.4
%
9.58
5642
28737
2299
9923
1.49
56.66
7.1
7.7
104.8
104.5
mmol/l
1.67
2268
9647
5873
29764
1.33
56.37
12.0
9.0
0.0
0.0
e9/l
0.19
4897
24484
211
396
3.28
47.79
2.8
1.3
14.3
9.4
iu/l
3.67
170
319
4858
24559
1.30
44.32
2.8
2.9
244.4
182.5
ug/l
13.54
4350
22482
1107
4307
1.61
42.66
8.0
11.7
—
—
—
0
0
12969
74784
1.39
42.15
12.4
9.4
27.1
29.1
u/l
12.60
12489
71748
284
685
2.56
41.70
1.3
1.3
—
—
—
0
0
315
809
2.41
40.66
2.9
1.9
151.7
1319.4
u/ml
0.85
284
728
6385
33700
1.27
40.41
5.5
5.6
1.7
1.8
e9/l
2.32
5502
29310
6419
33997
1.26
38.96
5.6
5.7
0.2
0.2
e9/l
9.28
5504
29478
13311
77314
1.40
38.42
28.7
20.4
230.1
229.0
e9/l
1.27
13027
74841
13313
77366
1.40
37.75
28.7
20.4
4.5
4.6
e12/l
206.11
12977
74567
13314
77375
1.40
37.72
28.7
20.4
6.8
6.9
e9/l
2.69
12987
74596
13314
77377
1.40
37.68
28.9
20.5
135.2
141.0
g/l
279.56
13154
75958
2569
12089
1.36
37.39
2.0
1.8
—
—
—
0
0
4248
21501
1.29
36.74
2.6
2.4
59.1
61.5
u/l
1.35
3904
19831
1982
9006
1.39
35.60
2.6
2.2
1.8
1.7
%
0.85
1735
7894
2070
9494
1.38
35.13
6.3
6.7
1.0
1.0
mmol/l
0.73
1935
8859
1582
6935
1.44
34.71
3.0
2.5
8.7
9.6
umol/l
0.85
1405
6154
86
102
5.17
34.54
1.1
1.1
—
—
—
0
0
1539
6730
1.44
34.18
2.8
2.3
67.7
68.1
e9/l
0.14
1192
5140
322
921
2.16
32.56
3.4
3.0
1.8
1.4
%
0.78
230
686
2450
11686
1.33
32.06
2.6
2.7
12.5
13.2
umol/l
5.53
2254
10801
2303
10893
1.34
31.87
2.6
2.7
2.2
2.2
g/l
3.98
2112
10057
1276
5458
1.47
31.70
2.2
2.1
0.2
0.2
g/l
0.95
1176
4942
1237
5261
1.47
31.63
3.5
3.8
0.2
0.1
%
2.44
416
1213
2169
10260
1.34
29.82
2.7
2.8
23.0
23.8
%
1.79
1807
8683
1171
5004
1.46
29.16
3.3
3.6
1.1
0.5
%
3.58
317
964
9904
55983
1.23
28.71
24.1
16.8
13.8
13.7
%
15.49
9766
54587
3406
17195
1.27
28.69
1.6
1.6
18.4
18.8
nmol/l
1.11
2905
14804
1068
4500
1.48
28.53
1.6
1.6
—
—
—
0
0
8917
49891
1.22
28.42
3.9
3.9
14.2
11.4
mm/h
38.82
8067
45940
4170
21598
1.25
28.06
3.6
2.8
35.2
37.5
u/l
0.83
3940
20302
1011
4241
1.49
27.58
8.8
10.8
23.8
24.3
mmol/l
4.90
958
3855
1866
8745
1.34
27.10
7.1
8.4
95.7
95.0
%
4.77
1768
8442
810
3258
1.55
26.88
2.0
2.0
3.6
2.1
ug/l
1.21
701
2892
2517
12333
1.29
26.60
2.0
2.1
30.3
30.4
s
0.49
2446
11980
1685
7826
1.35
25.88
7.6
9.1
121.4
125.4
g/l
11.52
1608
7567
1519
6975
1.37
25.05
7.0
8.0
1.4
1.5
mmol/l
1.54
1463
6697
1992
9543
1.32
24.70
7.0
8.1
0.5
1.1
mmol/l
8.42
1544
7421
1984
9547
1.31
23.76
6.9
8.1
12.3
11.5
kpa
10.32
1868
9114
1983
9554
1.31
23.51
7.0
8.1
5.1
5.0
kpa
1.89
1863
9123
732
2990
1.52
22.63
2.0
1.8
—
—
—
0
0
673
2747
1.52
20.89
1.9
1.7
—
—
—
0
0
69
108
3.91
20.38
5.8
1.1
36.3
146.4
u/ml
0.48
23
15
10664
61482
1.20
20.34
20.4
15.4
39.1
40.7
%
36.93
6759
41094
4565
24507
1.20
19.92
3.0
3.2
1868.0
1680.2
ng/l
1.28
3940
21253
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
660
2721
1.50
19.55
2.9
3.2
0.4
0.3
u/ml
0.78
370
1602
995
4441
1.39
19.36
1.8
1.6
—
—
—
0
0
248
791
1.93
18.95
1.5
1.2
—
—
—
0
0
1003
4541
1.37
17.90
6.5
8.5
24.4
24.6
mmol/l
0.93
997
4490
1279
6048
1.32
17.10
3.2
2.5
64.5
63.0
ml/min/173m2
0.60
506
2297
5534
30508
1.17
16.86
4.0
3.9
53.9
95.4
ng/l
3.48
4468
23252
198
611
1.99
16.67
3.2
3.0
59.7
62.5
%
0.74
116
392
1871
9318
1.26
16.67
4.6
4.9
31.2
31.4
%
0.33
1227
6494
1316
6275
1.31
16.56
2.7
1.7
65.8
67.0
g/l
6.57
1193
5719
111
270
2.52
16.33
1.5
1.3
4.3
4.2
mg/l
0.09
102
262
179
537
2.05
16.28
1.5
1.2
97.7
54.7
u/l
2.04
128
326
19
0
+∞
16.18
1.1
0.0
—
—
—
0
0
24
15
9.78
15.96
8.4
4.3
0.3
0.3
umol/l
—
24
8
1176
5599
1.31
14.93
2.4
2.4
35.2
51.7
u/l
1.09
981
4775
1555
7674
1.26
14.89
7.2
8.1
11.4
11.2
mmol/l
0.54
1478
7272
836
3790
1.37
14.79
1.7
1.6
1.6
1.5
g/l
2.82
713
3226
1691
8437
1.25
14.73
1.9
1.7
—
—
—
0
0
1098
5200
1.31
14.48
9.0
10.5
0.6
0.7
%
13.92
1089
5163
1191
9149
0.78
14.36
1.8
1.9
1.6
1.6
%
0.51
994
7864
764
3434
1.38
14.26
4.4
5.3
0.9
0.9
%
0.40
699
3251
28
26
6.58
14.17
1.0
1.1
—
—
—
0
0
401
1594
1.55
14.13
1.6
1.5
—
—
—
0
0
396
1580
1.54
13.74
1.4
1.4
—
—
—
0
0
305
1147
1.64
13.55
1.7
1.6
—
—
—
0
0
771
3501
1.36
13.51
4.4
5.2
1.6
1.7
%
2.20
703
3317
1096
5238
1.30
13.51
8.9
10.3
1.2
1.4
%
6.57
1088
5197
386
1542
1.54
13.33
1.6
1.6
—
—
—
0
0
223
774
1.77
13.25
1.1
1.1
—
—
—
0
0
5488
30629
1.15
13.15
2.0
2.0
93.0
91.8
pmol/l
1.08
3163
17565
96
244
2.41
13.00
3.5
3.1
—
—
—
0
0
2746
14550
1.19
12.93
1.8
1.8
1128.1
1130.2
nmol/l
0.04
2018
11105
4232
23228
1.16
12.73
2.0
2.1
78.3
75.3
nmol/l
8.98
3670
20492
913
4292
1.32
12.70
1.6
1.5
—
—
—
0
0
1672
8482
1.23
12.42
1.9
1.8
—
—
—
0
0
415
1717
1.49
12.21
2.2
1.4
7.6
6.1
u/l
2.87
336
1388
85
211
2.47
12.12
2.0
1.4
—
—
—
0
0
1088
5274
1.28
12.02
3.6
3.6
1.5
1.6
mmol/l
0.09
780
3801
431
1803
1.47
12.01
4.1
4.6
2.2
2.4
mmol/l
0.73
277
1187
431
1804
1.47
11.98
4.1
4.6
4.9
5.0
kpa
1.19
424
1754
2824
15094
1.17
11.87
4.3
3.6
1.0
1.0
kg/l
0.53
462
2181
1134
5546
1.27
11.65
3.7
3.6
5.1
5.1
kpa
0.20
1040
5118
116
338
2.10
11.52
1.3
1.5
—
—
—
0
0
83
210
2.42
11.41
2.0
1.4
—
—
—
0
0
108
308
2.15
11.33
1.9
1.5
8.3
5.5
u/l
0.89
55
132
83
211
2.41
11.30
2.0
1.4
—
—
—
0
0
427
1813
1.45
11.07
5.6
7.3
105.0
105.1
mmol/l
0.21
369
1665
102
287
2.18
11.06
1.8
1.4
—
—
—
0
0
102
288
2.17
10.98
1.8
1.4
—
—
—
0
0
102
288
2.17
10.98
1.8
1.4
—
—
—
0
0
102
288
2.17
10.98
1.8
1.4
—
—
—
0
0
97
270
2.20
10.81
1.2
1.1
20.1
23.9
u/l
0.40
60
205
409
1734
1.45
10.70
2.5
2.7
16.1
16.8
%
2.70
234
952
96
270
2.18
10.45
1.2
1.1
68.9
92.5
u/l
2.31
64
216
540
2421
1.37
10.32
2.8
1.6
3.7
2.6
ratio
0.42
43
189
370
1554
1.46
10.18
1.7
1.6
—
—
—
0
0
439
1910
1.42
10.01
2.8
3.0
7.8
7.9
kpa
0.21
410
1776
549
2496
1.36
9.63
2.9
1.6
72.3
39.4
mg/l
0.71
422
1996
549
2501
1.35
9.52
2.9
1.6
66.2
53.9
mg/l
0.62
419
2000
12
384
0.19
9.41
12.8
12.5
1021.9
801.1
nmol/l
0.61
12
364
437
1922
1.40
9.40
1.3
1.3
—
—
—
0
0
787
3800
1.28
9.01
4.2
4.5
23.7
23.9
mmol/l
0.93
703
3347
188
699
1.65
8.90
2.4
2.9
—
—
—
0
0
193
726
1.63
8.75
1.5
1.3
—
—
—
0
0
1503
7810
1.19
8.64
4.1
4.1
1.6
1.7
mmol/l
0.70
1208
6329
189
720
1.61
8.18
1.5
1.3
—
—
—
0
0
189
720
1.61
8.18
1.5
1.3
—
—
—
0
0
287
1200
1.47
8.17
4.7
7.0
4534.1
974.0
iu/ml
0.44
37
204
1497
7827
1.19
8.01
4.1
4.1
5.8
5.8
kpa
1.82
1466
7594
565
2656
1.31
7.96
2.5
2.9
—
—
—
0
0
190
731
1.59
7.91
1.5
1.3
—
—
—
0
0
194
752
1.58
7.84
1.5
1.3
—
—
—
0
0
187
719
1.60
7.82
1.5
1.3
—
—
—
0
0
257
1063
1.48
7.75
1.5
1.5
32.0
30.9
g/l
0.58
213
945
279
1174
1.46
7.72
3.2
3.4
59.5
59.0
%
0.23
279
1174
11722
69586
1.12
7.65
5.0
5.0
6.1
6.2
mmol/l
8.15
10372
63345
691
3356
1.27
7.59
3.9
3.9
24.5
24.6
mmol/l
0.24
630
3091
196
769
1.56
7.54
1.5
1.7
—
—
—
0
0
28
48
3.57
7.53
1.2
1.1
—
—
—
0
0
20
26
4.70
7.48
1.0
1.0
—
—
—
0
0
184
714
1.58
7.43
1.4
1.3
525.3
461.3
u/l
0.14
171
672
422
1926
1.35
7.32
1.8
2.3
91.3
85.6
%
6.11
405
1815
933
4718
1.22
7.15
2.5
1.8
367.4
359.2
nmol/l
0.50
868
4296
345
2848
0.73
7.10
1.4
1.6
—
—
—
0
0
169
651
1.59
7.06
1.7
1.5
—
—
—
0
0
10206
60230
1.10
7.03
3.7
3.7
2.5
2.2
mu/l
0.49
8894
54130
420
1929
1.34
7.01
1.9
2.5
3.7
3.6
g/l
0.43
399
1846
183
721
1.56
6.95
1.4
1.4
6.3
6.5
mmol/l
0.43
155
660
147
553
1.63
6.77
1.7
1.3
—
—
—
0
0
147
553
1.63
6.77
1.7
1.3
—
—
—
0
0
147
553
1.63
6.77
1.7
1.3
—
—
—
0
0
288
1253
1.41
6.72
1.8
2.0
1.9
1.8
mmol/l
0.31
281
1222
381
3066
0.75
6.61
1.4
1.7
—
—
—
0
0
117
417
1.72
6.60
1.5
1.3
—
—
—
0
0
87
283
1.88
6.59
1.8
2.1
22.7
16.7
%
1.63
29
113
115
409
1.72
6.54
1.5
1.3
—
—
—
0
0
375
1714
1.34
6.50
2.1
2.6
202.4
198.3
%
0.37
361
1626
124
1218
0.62
6.44
3.4
4.8
323.3
351.9
umol/l
1.53
94
1024
81
261
1.90
6.33
1.8
2.1
—
—
—
0
0
91
305
1.83
6.31
1.8
1.2
110.7
103.4
u/l
0.17
79
255
157
612
1.57
6.29
1.8
1.5
—
—
—
0
0
145
555
1.60
6.27
1.8
1.9
2.0
1.4
u/field
0.56
63
230
112
401
1.71
6.24
1.4
1.4
—
—
—
0
0
483
2309
1.29
6.10
1.8
1.8
—
—
—
0
0
262
1142
1.41
6.10
6.3
6.2
11.9
11.5
mg/l
0.57
245
1051
204
849
1.47
6.07
1.5
1.5
57303.6
64981.5
e6/l
0.15
126
522
222
942
1.45
5.99
1.5
1.5
2081.6
3892.0
e6/l
0.85
157
692
86
289
1.82
5.95
1.8
1.2
36.1
26.0
u/l
0.53
74
240
690
5102
0.82
5.90
1.9
2.0
—
—
—
0
0
217
924
1.44
5.77
2.3
3.0
582.3
10599.9
u/ml
0.49
16
54
481
2317
1.28
5.74
3.1
3.2
24.5
24.5
mmol/l
0.00
423
2056
145
568
1.56
5.73
1.3
1.3
15.2
13.5
u/l
0.24
132
526
45
120
2.29
5.73
2.0
1.4
42.4
34.9
u/l
0.12
39
107
286
1280
1.37
5.72
1.3
1.5
—
—
—
0
0
2185
12032
1.13
5.68
27.5
29.1
1.5
1.5
inr
0.53
343
1587
211
900
1.44
5.57
1.9
2.2
24.9
26.9
mg/l
0.15
51
251
1366
9487
0.87
5.56
1.2
1.2
31.3
43.8
iu/ml
1.92
377
2843
109
401
1.66
5.56
1.4
1.4
—
—
—
0
0
46
126
2.23
5.53
1.8
2.4
—
—
—
0
0
7657
44846
1.08
5.50
3.3
3.1
58.0
56.8
u/l
0.45
6993
41377
223
964
1.42
5.48
1.5
1.5
—
—
—
0
0
401
1901
1.30
5.44
2.2
2.3
127.2
134.3
g/l
5.27
305
1398
103
377
1.67
5.37
1.7
1.8
2.5
2.9
u/field
0.19
71
273
253
1127
1.38
5.25
1.3
1.3
—
—
—
0
0
98
357
1.68
5.21
2.6
2.1
510.4
690.9
e6/l
1.95
45
153
143
572
1.53
5.20
1.5
1.4
—
—
—
0
0
4453
28883
0.92
5.20
4.0
4.2
9.1
9.4
mg/mmol
0.12
2924
19966
75
253
1.81
5.18
1.7
2.0
—
—
—
0
0
2538
14170
1.11
5.16
1.6
1.8
1.7
1.3
mg/l
3.32
1981
11069
62
197
1.93
5.13
1.5
1.8
2183.5
13883.0
u/ml
—
6
32
233
1029
1.39
5.10
1.3
1.5
—
—
—
0
0
122
473
1.58
5.09
1.5
2.0
—
—
—
0
0
245
2017
0.74
5.07
1.5
1.8
3.9
4.2
mg/l
0.15
178
1425
228
1005
1.39
5.05
1.3
1.3
—
—
—
0
0
15
283
0.32
4.99
2.2
2.7
124.4
137.2
nmol/l
0.27
15
245
83
296
1.72
4.79
2.8
2.0
576.9
460.1
e6/l
0.47
71
255
396
1910
1.27
4.75
3.0
2.8
1.7
1.8
mg/l
0.24
356
1701
506
2512
1.24
4.74
2.3
1.6
1.3
0.5
g/l
3.26
428
2163
4288
27770
0.92
4.73
3.1
3.4
8.4
8.6
mmol/l
2.94
3432
23419
121
479
1.55
4.66
1.4
1.4
—
—
—
0
0
1216
8408
0.87
4.65
2.4
2.5
7.2
9.5
ug/l
3.12
1043
7507
866
4533
1.18
4.65
4.3
4.9
107.8
108.8
ng/l
0.09
747
3942
36
454
0.48
4.63
5.1
6.4
32.2
512.2
u/ml
—
6
108
518
3841
0.82
4.62
1.8
1.8
41.3
43.0
nmol/l
0.98
503
3703
2826
15949
1.10
4.61
1.8
1.7
26473584.9
31986729.7
pmol/l
0.23
2274
13165
842
4401
1.18
4.60
2.7
2.1
10.7
11.3
g/l
2.43
760
4000
29
394
0.45
4.59
1.2
1.4
—
—
—
0
0
283
1313
1.32
4.57
1.4
1.3
—
—
—
0
0
4221
27311
0.92
4.51
3.2
3.4
313.0
253.6
mg/l
0.46
2792
18993
375
1816
1.27
4.39
3.6
3.3
7.3
8.0
mmol/l
5.80
366
1777
22
323
0.41
4.27
15.7
12.9
0.6
0.7
mmol/l
0.37
22
291
392
1916
1.26
4.26
3.6
3.2
1.6
1.7
mmol/l
0.95
383
1871
239
1920
0.76
4.24
1.3
1.5
1.0
0.8
nmol/l
1.86
204
1584
52
167
1.90
4.24
1.4
1.2
11.4
11.0
u/l
0.05
44
111
85
317
1.64
4.22
1.5
1.3
—
—
—
0
0
85
317
1.64
4.22
1.5
1.3
—
—
—
0
0
454
3376
0.82
4.20
1.3
1.3
383.9
304.5
u/ml
0.52
423
3159
234
1071
1.34
4.18
2.7
2.4
4.1
4.1
mmol/l
0.23
228
1062
234
1071
1.34
4.18
2.7
2.4
105.8
105.8
mmol/l
0.01
228
1061
588
3008
1.20
4.14
2.0
1.4
7.4
7.4
g/l
0.31
427
2263
588
3008
1.20
4.14
2.0
1.4
—
—
—
0
0
586
2997
1.20
4.14
2.0
1.4
4.0
4.0
g/l
0.04
412
2178
77
283
1.66
4.05
2.9
2.0
0.3
0.2
e9/l
0.37
70
254
135
566
1.46
4.02
1.4
1.4
12.2
13.6
u/l
1.75
129
543
93
869
0.65
4.02
1.4
1.2
1.4
1.4
nmol/l
0.07
83
790
1189
6445
1.14
4.00
3.2
3.3
4.6
4.6
kpa
0.08
1161
6214
8
5
9.77
3.99
1.0
1.0
—
—
—
0
0
26
65
2.44
3.89
1.0
1.3
—
—
—
0
0
75
278
1.65
3.85
2.4
2.7
27.4
39.5
%
3.21
23
93
547
2806
1.20
3.77
2.0
1.5
10.2
10.5
g/l
0.74
455
2382
163
1356
0.73
3.73
1.1
1.1
65.5
214.1
iu/ml
0.59
37
267
326
1587
1.26
3.72
1.4
1.3
—
—
—
0
0
352
2650
0.81
3.71
2.2
2.4
97.7
132.7
ug/min
0.85
195
1624
326
1588
1.26
3.70
1.4
1.3
—
—
—
0
0
81
310
1.60
3.68
1.2
1.3
—
—
—
0
0
81
310
1.60
3.68
1.2
1.3
—
—
—
0
0
11330
67830
1.08
3.65
6.3
6.7
40.5
41.2
mmol/mol
9.94
10224
62815
261
2027
0.78
3.63
1.1
1.2
0.2
0.6
u/ml
1.93
20
179
1280
8668
0.89
3.53
1.2
1.2
11.0
14.0
u/ml
0.78
408
3237
82
763
0.65
3.53
1.0
1.1
0.6
1.4
u/ml
1.80
31
323
284
2174
0.79
3.51
1.6
1.6
19458.1
15608.7
e6/l
0.59
200
1610
48
161
1.82
3.50
3.5
2.2
—
—
—
0
0
55
554
0.60
3.38
2.0
2.4
—
—
—
0
0
48
496
0.59
3.28
1.0
1.1
1.0
2.8
u/ml
1.79
14
209
36
402
0.55
3.27
1.0
1.0
0.3
0.4
u/ml
—
9
105
22
56
2.40
3.21
1.5
1.3
—
—
—
0
0
260
1984
0.80
3.16
1.6
1.6
24.1
3.5
iu/ml
0.51
60
454
44
460
0.58
3.16
1.0
1.1
1.0
2.5
u/ml
0.89
12
183
540
2817
1.18
3.14
2.1
1.5
3.1
3.0
g/l
1.33
419
2230
60
578
0.63
3.09
1.0
1.1
1.2
1.6
u/ml
0.24
14
134
7
6
7.13
3.07
1.1
1.0
—
—
—
0
0
84
741
0.69
2.83
1.2
1.1
3.5
1.8
iu/ml
—
7
25
1312
7310
1.10
2.80
2.7
3.2
232.7
252.2
ng/l
0.72
1194
6712
5
107
0.29
2.80
1.0
1.0
—
—
—
0
0
17
41
2.53
2.78
6.2
1.1
—
—
—
0
0
73
658
0.68
2.77
1.9
2.3
—
—
—
0
0
447
2325
1.18
2.74
2.1
1.5
37.0
37.5
g/l
0.90
381
2014
336
1704
1.21
2.73
3.3
3.3
33.3
28.7
mg/l
1.27
214
1129
266
1982
0.82
2.65
1.5
1.7
—
—
—
0
0
25
74
2.06
2.65
1.0
1.2
—
—
—
0
0
99
428
1.41
2.65
3.4
3.8
—
—
—
0
0
1008
5569
1.11
2.56
6.6
7.7
24.4
24.4
mmol/l
0.15
926
5228
434
2270
1.17
2.52
2.2
1.5
0.1
0.0
g/l
0.93
399
2071
7
120
0.36
2.50
2.0
3.5
—
—
—
0
0
161
760
1.30
2.48
1.4
1.2
0.6
2.0
nmol/l
0.49
154
736
23
69
2.04
2.38
3.4
1.6
42.7
131.5
u/l
—
6
28
55
216
1.56
2.37
1.3
1.4
3.8
3.7
mmol/l
0.05
47
194
160
762
1.28
2.33
1.4
1.2
0.1
0.2
nmol/l
0.71
14
64
34
119
1.75
2.27
1.8
1.7
85.1
116.4
ug/l
1.08
28
96
86
720
0.73
2.21
1.0
1.0
704.9
730.2
ng/l
0.25
63
478
86
719
0.73
2.19
1.0
1.0
36.4
41.0
ng/l
0.63
64
484
734
4024
1.12
2.19
2.8
2.9
1.2
1.3
%
0.66
726
4005
86
718
0.73
2.18
1.0
1.0
276.5
303.6
ng/l
0.58
66
493
400
2110
1.16
2.14
2.2
1.5
0.0
0.0
g/l
0.80
366
1915
393
2073
1.16
2.11
2.2
1.5
0.0
0.0
g/l
0.00
363
1909
714
3920
1.12
2.09
2.8
2.9
0.6
0.7
%
1.08
677
3761
2671
15499
1.06
2.09
3.9
4.1
783.3
840.1
ng/l
0.06
2291
13309
6
8
4.58
2.07
11.2
1.0
—
—
—
0
0
72
612
0.72
2.06
1.2
1.2
74.7
166.0
titre
2.02
17
106
54
220
1.50
2.03
1.3
1.3
125.3
33.9
ug/l
0.55
26
94
125
589
1.30
2.02
1.5
1.3
—
—
—
0
0
952
5319
1.10
2.00
3.5
3.5
127.1
132.8
g/l
10.62
929
5191
14
176
0.49
1.98
2.2
2.5
—
133.6
—
0
25
16
192
0.51
1.97
2.7
3.0
6.2
7.0
mg/l
0.41
11
161
45
178
1.54
1.94
1.4
1.4
17.2
27.4
%
1.62
35
145
44
174
1.55
1.90
1.1
1.2
—
—
—
0
0
11983
72307
1.05
1.89
5.2
5.5
2.6
2.5
mmol/l
2.84
10700
66908
20
63
1.94
1.87
1.0
1.1
5.7
17.0
iu/ml
—
7
22
26
90
1.76
1.85
2.2
2.2
—
—
—
0
0
26
90
1.76
1.85
2.2
2.2
—
—
—
0
0
250
1800
0.85
1.83
1.5
1.6
—
—
—
0
0
90
724
0.76
1.83
1.1
1.1
5.5
8.5
au/ml
—
10
38
57
242
1.44
1.79
1.3
1.4
2.2
2.8
%
0.28
47
193
256
1829
0.85
1.73
1.7
1.9
10.9
11.3
mg/l
0.37
232
1713
173
1279
0.82
1.72
1.1
1.1
3.6
8.5
u/ml
1.26
14
132
56
239
1.43
1.72
1.2
1.7
—
—
—
0
0
3777
22255
1.05
1.67
3.0
2.7
5641.7
5408.5
umol/l
0.09
3186
19264
276
1448
1.17
1.66
2.1
1.2
39.8
23.5
u/l
1.20
236
1245
64
282
1.39
1.66
1.4
1.4
63.2
65.4
%
0.20
50
222
7629
45660
1.04
1.60
3.0
2.9
15.0
14.9
pmol/l
1.73
6642
40638
25
90
1.70
1.59
1.3
1.4
31.5
42.3
u/l
0.36
18
65
107
513
1.28
1.59
1.2
1.2
—
—
—
0
0
62
513
0.74
1.57
1.2
1.3
1.3
1.3
nmol/l
0.15
50
377
69
561
0.75
1.56
1.1
1.2
—
—
—
0
0
31
289
0.65
1.53
1.1
1.0
—
—
—
0
0
83
388
1.31
1.50
1.5
1.4
3.7
4.0
%
0.10
19
98
157
792
1.21
1.50
3.1
3.8
—
—
—
0
0
404
2761
0.89
1.47
4.6
4.9
3.9
4.0
mmol/l
0.69
373
2588
764
4305
1.09
1.41
3.8
3.5
24.9
25.0
mmol/l
0.35
738
4169
11716
70807
1.04
1.40
4.7
4.9
4.4
4.3
mmol/l
10.08
10532
65842
94
720
0.80
1.37
1.1
1.1
—
—
—
0
0
10
27
2.26
1.37
1.2
1.6
1.6
0.8
u/field
—
5
14
27
104
1.59
1.37
1.4
1.5
—
—
—
0
0
101
493
1.25
1.34
1.3
1.2
2.2
2.1
mmol/l
0.21
95
459
429
2901
0.90
1.33
1.7
1.8
38.2
37.8
u/l
0.12
365
2487
708
3990
1.09
1.33
4.4
4.1
47.4
48.3
%
0.46
699
3937
15
49
1.87
1.32
3.7
1.2
—
—
—
0
0
213
1504
0.86
1.31
1.3
1.3
43.3
18.8
e6/l
0.36
157
1173
11276
68124
1.04
1.31
4.2
4.4
1.3
1.3
mmol/l
4.39
9963
62548
370
2520
0.89
1.31
1.4
1.4
—
—
—
0
0
29
116
1.53
1.27
1.4
1.4
9.6
7.9
%
0.23
15
50
214
1506
0.87
1.27
1.4
1.4
505.2
1527.3
e6/l
1.68
167
1242
194
1017
1.17
1.26
5.9
14.2
7.1
7.7
mmol/l
2.36
166
829
154
1109
0.85
1.23
1.3
1.3
54.8
105.3
pmol/l
1.02
86
319
320
1740
1.13
1.23
1.4
1.5
258.9
267.5
ug/g
0.28
193
1059
141
1022
0.84
1.22
1.1
1.1
—
—
—
0
0
11
33
2.04
1.21
3.4
1.4
—
—
—
0
0
1699
10860
0.95
1.20
1.2
1.2
1.9
2.1
u/ml
0.21
415
2915
203
1427
0.87
1.20
1.3
1.3
—
—
—
0
0
1045
6003
1.07
1.20
2.2
2.5
159.1
171.5
ug/g
0.41
812
4831
260
1794
0.88
1.17
1.4
1.4
0.2
0.2
g/l
0.61
246
1709
27
242
0.68
1.16
1.1
1.1
—
—
—
0
0
37
313
0.72
1.15
1.2
1.3
65.4
60.3
%
0.41
31
275
197
1382
0.87
1.15
1.1
1.1
—
—
—
0
0
118
862
0.83
1.14
2.0
2.3
697.7
696.2
ml
0.01
67
580
205
1090
1.15
1.13
1.2
1.2
—
—
—
0
0
23
90
1.56
1.13
1.2
1.1
—
—
—
0
0
252
1732
0.89
1.09
1.3
1.3
—
—
—
0
0
41
337
0.74
1.08
8.7
7.8
—
—
—
0
0
40
330
0.74
1.08
1.1
1.2
1.1
1.1
ratio
0.31
12
102
423
2826
0.91
1.08
1.6
1.6
112.9
272.7
titre
2.65
14
111
413
2298
1.10
1.08
3.1
3.2
4.5
4.4
pmol/l
0.56
364
2056
11
119
0.56
1.06
1.0
1.1
—
—
—
0
0
61
290
1.29
1.06
1.1
1.2
—
—
—
0
0
116
593
1.20
1.05
1.3
1.4
279.5
280.6
mosm/kgh2o
0.16
88
448
7
20
2.14
1.04
1.0
1.4
—
—
—
0
0
115
833
0.84
1.03
2.5
2.2
—
0.4
—
0
7
100
733
0.83
1.03
1.2
1.2
177.7
194.0
miu/ml
0.15
26
202
9
99
0.55
1.02
1.0
1.0
—
—
—
0
0
9
100
0.55
1.01
1.6
1.6
—
—
—
0
0
0
19
0.00
1.01
0.0
6.5
—
0.3
—
0
19
11601
70238
1.03
1.01
4.7
4.8
1.3
1.3
mmol/l
22.19
10349
64858
34
149
1.39
1.00
11.4
10.8
5.4
5.9
mmol/l
0.38
34
149
271
1843
0.90
1.00
1.4
1.4
1.2
1.2
g/l
0.07
259
1757
126
902
0.85
1.00
1.3
1.3
152407.3
142858.7
e6/l
0.06
89
637
6
15
2.44
0.98
2.2
1.1
988.2
537.5
nmol/l
—
6
15
8
89
0.55
0.97
2.3
2.0
15.0
16.8
umol/l
—
8
89
59
285
1.26
0.93
2.4
2.4
—
—
—
0
0
59
285
1.26
0.93
2.4
2.4
—
—
—
0
0
5792
34740
1.03
0.93
2.2
2.2
—
—
—
0
0
31
136
1.39
0.92
1.4
1.2
54.6
63.8
mu/l
0.15
24
96
11
37
1.82
0.92
1.3
1.4
—
—
—
0
0
43
339
0.77
0.89
2.2
2.4
53.5
55.7
umol/l
0.27
33
281
555
3626
0.93
0.87
1.6
1.5
21.2
16.6
u/ml
0.17
13
94
421
2777
0.92
0.86
1.9
1.9
185.5
201.7
pmol/l
2.04
392
2618
55
267
1.26
0.85
1.8
1.5
0.4
0.3
mmol/l
0.07
50
254
21
87
1.47
0.85
1.0
1.1
—
—
—
0
0
15
140
0.65
0.84
1.7
1.8
—
—
—
0
0
13
48
1.65
0.83
1.5
1.5
0.7
0.6
umol/l
—
6
42
22
93
1.44
0.81
3.1
2.5
0.2
0.2
u/field
0.08
22
93
5
60
0.51
0.81
1.0
1.1
—
—
—
0
0
101
720
0.86
0.80
1.1
1.1
—
—
—
0
0
1007
6436
0.95
0.78
1.2
1.3
—
—
—
0
0
13
49
1.62
0.77
1.2
1.4
—
—
—
0
0
36
168
1.31
0.77
1.8
2.8
6.8
8.4
mmol/l
2.28
23
98
75
544
0.84
0.75
1.1
1.2
10.9
12.3
mmol/l
0.87
23
200
11
40
1.68
0.74
1.0
1.1
5.9
6.0
mmol/l
0.03
11
25
38
180
1.29
0.74
1.1
1.1
—
—
—
0
0
112
782
0.87
0.70
1.2
1.4
1.3
1.5
promille
0.88
94
596
198
1094
1.11
0.68
1.6
1.5
62.4
62.4
%
0.00
130
735
7
26
1.64
0.66
2.4
1.5
0.9
1.8
%
—
7
26
96
508
1.15
0.66
1.1
1.1
—
—
—
0
0
114
790
0.88
0.66
1.2
1.1
7.4
7.5
mmol/l
0.11
86
552
257
1705
0.92
0.65
1.2
1.2
120.0
103.5
titre
0.12
24
163
23
103
1.36
0.65
1.1
1.0
—
—
—
0
0
78
407
1.17
0.64
1.0
1.1
—
—
—
0
0
31
241
0.78
0.63
1.1
1.3
211.7
143.8
nmol/l
0.56
23
181
68
352
1.18
0.62
2.3
6.9
54.2
2220.4
mg/l
1.34
50
261
28
220
0.78
0.62
2.5
3.2
15.9
27.3
mu/l
2.37
22
203
494
3187
0.94
0.59
4.1
4.6
1.4
1.4
mmol/l
0.59
479
3127
57
412
0.84
0.59
1.1
1.1
5.4
6.8
nmol/l
0.21
14
86
51
372
0.84
0.58
1.4
1.2
—
—
—
0
0
32
245
0.80
0.58
1.1
1.1
101.1
101.6
%
0.03
25
195
21
170
0.75
0.58
1.1
1.1
—
—
—
0
0
153
844
1.11
0.58
1.8
1.3
237.1
256.5
pmol/l
0.49
111
609
14
59
1.45
0.56
1.1
1.0
—
—
—
0
0
154
852
1.10
0.56
1.5
1.4
26.5
24.9
%
0.24
94
580
1650
9799
1.03
0.55
1.5
1.3
2.7
3.0
g/l
4.08
1002
5947
67
352
1.16
0.54
1.3
1.2
—
—
—
0
0
119
809
0.90
0.53
1.5
2.1
777.1
3461.7
titre
—
7
48
33
162
1.24
0.53
1.1
1.1
—
—
—
0
0
356
2308
0.94
0.53
1.3
1.5
7.0
9.8
iu/ml
—
8
50
32
157
1.24
0.52
1.3
1.2
280.4
261.4
pmol/l
0.12
21
117
3242
19452
1.02
0.51
1.7
1.7
1.4
1.4
mmol/l
1.69
2563
16007
37
185
1.22
0.51
1.0
1.1
—
—
—
0
0
29
220
0.80
0.51
1.2
1.7
12.7
13.2
g/l
0.10
22
163
7
27
1.58
0.50
1.0
1.0
242.3
233.8
nmol/l
—
7
27
67
355
1.15
0.50
1.3
1.2
—
—
—
0
0
4032
24258
1.02
0.49
2.2
2.3
240.3
272.8
u/l
1.30
3779
22785
284
1625
1.07
0.49
1.5
1.6
—
—
—
0
0
13
56
1.42
0.48
1.1
1.3
1.3
1.3
%
0.16
13
56
40
291
0.84
0.47
3.5
5.8
72.3
71.5
%
0.06
33
250
44
226
1.19
0.47
1.3
1.2
—
—
—
0
0
60
421
0.87
0.46
1.7
1.3
8.3
6.0
u/l
0.41
52
364
11
46
1.46
0.46
1.1
1.1
1.8
2.2
umol/24h
0.61
11
46
18
143
0.77
0.46
1.2
1.8
1.2
1.2
mmol/l
0.66
18
138
28
138
1.24
0.45
1.3
1.2
—
—
—
0
0
265
1722
0.94
0.45
1.2
1.3
609.2
580.4
mg/l
0.32
249
1638
8
33
1.48
0.44
1.0
1.1
—
—
—
0
0
231
1506
0.94
0.44
1.2
1.2
3.8
4.0
mmol/l
1.99
215
1418
52
274
1.16
0.43
1.5
1.4
0.1
0.1
nmol/l
0.05
41
223
18
84
1.31
0.43
1.6
1.6
37.9
44.1
umol/l
0.54
18
84
129
860
0.91
0.43
1.1
1.2
112.6
109.6
%
0.48
112
776
1590
9928
0.98
0.41
7.8
7.4
—
—
—
0
0
43
224
1.17
0.41
1.1
1.0
—
—
—
0
0
25
187
0.82
0.41
1.2
1.3
0.3
0.3
g/l
0.60
17
151
137
908
0.92
0.41
1.1
1.2
36.6
41.8
u/ml
—
5
81
0
12
0.00
0.40
0.0
1.3
—
—
—
0
0
29
213
0.83
0.40
1.1
1.2
—
—
—
0
0
97
652
0.91
0.39
1.1
1.1
72.9
25.7
au/ml
—
5
12
182
1036
1.07
0.39
1.2
1.3
278.3
286.2
u/ml
0.14
114
684
100
671
0.91
0.39
1.1
1.2
92.3
97.1
%
0.97
88
626
258
1668
0.94
0.39
1.6
1.7
—
—
—
0
0
78
530
0.90
0.39
2.5
3.3
13.1
13.2
%
0.58
78
522
9
41
1.34
0.38
1.1
1.1
—
—
—
0
0
22
108
1.24
0.38
1.4
1.3
1.0
0.9
mmol/l
0.01
16
66
67
365
1.12
0.37
2.3
2.4
—
—
—
0
0
17
81
1.28
0.36
1.1
1.2
—
—
—
0
0
25
184
0.83
0.36
1.1
1.1
—
—
—
0
0
11
49
1.37
0.35
4.2
3.9
—
—
—
0
0
13
60
1.32
0.34
1.1
1.1
14.9
8.4
u/l
0.58
13
60
6
27
1.36
0.34
1.0
1.1
20.1
22.1
%
—
6
22
6
27
1.36
0.34
1.0
1.1
36.9
36.4
%
—
6
22
6
27
1.36
0.34
1.0
1.1
7.9
8.9
%
—
6
22
22
110
1.22
0.33
4.2
4.9
45.1
48.4
ug/min
0.09
17
94
145
947
0.93
0.32
1.1
1.1
1.5
1.6
g/l
0.18
131
852
7
31
1.38
0.32
1.0
1.1
—
—
—
0
0
15
115
0.80
0.32
1.2
1.2
47.5
51.2
%
—
6
40
7
60
0.71
0.32
1.0
1.2
0.1
0.1
nmol/l
—
7
44
83
463
1.09
0.31
1.3
1.3
101.7
93.2
titre
—
6
41
30
212
0.86
0.29
1.1
1.2
—
—
—
0
0
25
129
1.18
0.29
1.2
1.2
4240.6
135.8
ng/l
0.52
14
91
54
296
1.11
0.29
1.1
1.3
41.5
41.3
g/l
0.04
28
163
88
582
0.92
0.29
1.0
1.1
—
—
—
0
0
56
378
0.90
0.28
1.5
1.3
3.2
1.4
u/ml
0.50
31
221
37
256
0.88
0.28
1.1
1.0
30.4
9.8
iu/ml
—
5
63
16
79
1.24
0.28
1.1
1.1
—
—
—
0
0
59
396
0.91
0.27
2.0
2.0
—
—
—
0
0
103
586
1.07
0.26
1.5
1.7
77.1
75.5
umol/l
—
7
35
5
46
0.66
0.26
1.4
1.4
—
—
—
0
0
192
1231
0.95
0.26
1.7
1.8
253.2
256.7
mu/l
0.09
185
1153
16
80
1.22
0.25
1.1
1.1
—
—
—
0
0
51
282
1.10
0.25
1.1
1.1
504.5
696.5
ng/l
0.19
16
72
149
864
1.05
0.23
1.4
1.6
4.7
15.5
iu/l
0.46
36
274
33
179
1.13
0.22
1.1
1.1
—
—
—
0
0
0
7
0.00
0.22
0.0
1.0
—
—
—
0
0
101
655
0.94
0.22
1.4
1.4
—
—
—
0
0
44
295
0.91
0.21
1.0
1.1
1.1
1.0
u/l
0.36
21
140
206
1309
0.96
0.21
1.1
1.2
3.3
7.8
u/ml
—
10
133
17
121
0.86
0.20
1.2
1.4
75.2
72.2
%
0.70
17
114
19
100
1.16
0.19
1.2
1.1
0.8
0.7
umol/24h
0.07
11
46
25
172
0.89
0.19
1.2
1.2
125.4
110.2
%
1.44
19
155
17
120
0.86
0.18
1.2
1.4
330.0
834.5
mu/l
0.87
17
113
58
379
0.93
0.17
1.2
1.1
—
—
—
0
0
58
379
0.93
0.17
1.2
1.1
—
—
—
0
0
338
2117
0.97
0.17
1.2
1.3
—
—
—
0
0
210
1325
0.97
0.17
1.1
1.2
3.7
7.9
u/ml
1.51
16
196
26
176
0.90
0.16
1.3
1.5
11.5
9.7
ug/l
0.74
26
176
19
102
1.14
0.15
1.0
1.1
—
—
—
0
0
348
2175
0.98
0.15
1.1
1.1
115.8
106.2
iu/ml
0.19
105
758
248
1473
1.03
0.15
1.2
1.2
—
—
—
0
0
35
232
0.92
0.15
1.5
1.3
38.2
35.9
%
0.12
28
150
18
124
0.89
0.14
5.7
4.7
—
—
—
0
0
59
382
0.94
0.14
1.2
1.1
—
—
—
0
0
59
382
0.94
0.14
1.2
1.1
—
—
—
0
0
63
407
0.94
0.14
1.1
1.2
—
—
—
0
0
16
111
0.88
0.14
1.4
1.4
83.0
84.7
%
—
7
53
27
150
1.10
0.14
1.3
1.2
1.7
1.3
mmol/l
1.35
20
83
59
381
0.95
0.13
1.2
1.1
—
—
—
0
0
312
1947
0.98
0.13
2.1
2.9
30.7
34.0
umol/l
1.89
252
1663
18
123
0.89
0.13
1.9
1.1
66.3
80.8
%
—
8
74
78
499
0.95
0.13
2.2
2.2
62.1
172.1
ug/min
1.47
24
135
89
567
0.96
0.13
1.0
1.1
3.1
3.7
u/ml
0.18
31
234
140
883
0.97
0.12
1.1
1.1
—
—
—
0
0
34
223
0.93
0.12
1.1
1.1
—
—
—
0
0
31
204
0.93
0.12
1.2
1.1
—
—
—
0
0
146
918
0.97
0.11
1.3
1.3
4.7
4.5
u/ml
0.04
56
335
141
887
0.97
0.11
1.3
1.3
3.8
4.1
u/ml
0.12
64
433
48
310
0.95
0.11
1.2
1.2
81.5
51.0
%
—
6
23
55
320
1.05
0.10
1.1
1.2
—
—
—
0
0
(3002348) Coagulation factor XII activity actual/normal in Platelet poor plasma by Coagulation assay
16
108
0.90
0.09
1.1
1.3
77.1
74.9
%
—
7
49
5
29
1.05
0.09
1.0
1.0
—
—
—
0
0
32
183
1.07
0.09
1.0
1.3
10.8
12.4
umol/l
0.16
25
130
24
158
0.93
0.09
1.2
1.2
—
—
—
0
0
19
106
1.09
0.09
1.0
1.1
—
—
—
0
0
273
1695
0.98
0.09
1.2
1.2
88.0
159.5
titre
—
5
37
53
338
0.96
0.08
1.1
1.1
—
—
—
0
0
11
59
1.14
0.08
1.0
1.1
—
—
—
0
0
6
35
1.05
0.08
1.0
1.2
200.5
271.3
u/l
—
6
28
5
38
0.80
0.08
1.2
1.4
—
—
—
0
0
31
178
1.06
0.08
1.1
1.1
—
—
—
0
0
31
178
1.06
0.08
1.1
1.2
—
—
—
0
0
681
4196
0.99
0.08
2.4
2.4
41.4
25.0
au/ml
0.82
23
158
273
1641
1.02
0.08
1.2
1.2
—
—
—
0
0
271
1629
1.02
0.08
1.2
1.2
—
—
—
0
0
74
467
0.97
0.08
1.4
1.5
14.9
14.9
umol/l
0.01
67
433
80
504
0.97
0.08
1.0
1.1
278.3
272.9
mg/l
0.31
73
460
18
101
1.09
0.07
1.6
2.9
—
—
—
0
0
20
113
1.08
0.07
1.1
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
59
347
1.04
0.07
1.1
1.1
—
—
—
0
0
625
3781
1.01
0.07
1.3
1.3
65.7
50.8
au/ml
0.71
35
173
7
49
0.87
0.07
1.1
1.2
6100.0
268.2
u/l
—
7
42
9
52
1.06
0.07
2.1
2.3
—
—
—
0
0
366
2260
0.99
0.07
1.0
1.1
—
—
—
0
0
25
162
0.94
0.06
1.6
1.8
116.6
152.1
ng/l
0.76
25
162
9
63
0.87
0.06
1.6
1.1
—
—
—
0
0
41
261
0.96
0.06
1.1
1.1
—
—
—
0
0
14
93
0.92
0.06
1.1
1.0
—
—
—
0
0
19
124
0.94
0.06
1.3
1.1
—
—
—
0
0
65
408
0.97
0.05
1.4
1.3
1.3
1.5
g/l
—
5
30
12
80
0.92
0.05
1.2
1.1
—
—
—
0
0
12
80
0.92
0.05
1.8
1.4
0.8
1.0
ml/s/173m2
—
7
56
17
111
0.93
0.05
1.1
1.2
—
—
—
0
0
30
175
1.05
0.05
1.1
1.1
—
—
—
0
0
263
1594
1.01
0.03
2.9
2.8
0.8
0.8
nmol/l
0.02
190
1212
69
414
1.02
0.02
1.1
1.1
55.2
46.2
mg/l
0.74
58
355
17
109
0.95
0.02
1.2
1.6
—
—
—
0
0
54
336
0.98
0.02
1.1
1.1
—
—
—
0
0
49
293
1.02
0.02
1.4
1.6
67.4
91.1
umol/l
0.61
22
137
179
1085
1.01
0.02
1.5
1.6
108.3
114.6
u/ml
0.37
38
238
184
1131
0.99
0.02
1.1
1.2
1.3
6.9
u/ml
—
8
92
535
3256
1.00
0.02
2.3
2.5
565.1
611.9
ug/l
0.14
518
3098
65
391
1.01
0.02
1.0
1.1
355.0
331.3
mg/l
0.30
54
349
44
274
0.98
0.01
1.4
2.4
1048.4
2494.9
e6/l
0.40
35
198
14
81
1.06
0.01
1.1
1.1
—
—
—
0
0
38
237
0.98
0.01
1.4
2.3
28787.2
5840.1
e6/l
0.61
25
130
23
136
1.03
0.01
1.3
1.2
—
—
—
0
0
97
587
1.01
0.01
1.7
1.6
36.9
28.2
u/ml
0.59
18
131
10
57
1.07
0.01
1.1
1.1
—
—
—
0
0
20
126
0.97
0.00
1.2
1.1
81.7
81.0
%
—
10
76
29
181
0.98
0.00
2.9
2.9
—
—
—
0
0
10
63
0.97
0.00
1.1
1.0
—
—
—
0
0
27
162
1.02
0.00
1.5
1.1
—
—
—
0
0
21
129
0.99
0.00
1.5
1.2
269.2
178.0
titre
—
5
11
25
152
1.00
0.00
1.1
1.2
206.2
14.1
mg/l
0.44
19
113
169
1030
1.00
0.00
1.5
1.5
—
—
—
0
0
30
181
1.01
0.00
1.2
1.4
—
—
—
0
0
202
1233
1.00
0.00
1.1
1.2
—
13.8
—
0
15
60
369
0.99
0.00
1.1
1.1
—
—
—
0
0
40
247
0.99
0.00
1.1
1.1
1448.9
1609.7
miu/ml
0.35
40
247
60
368
1.00
0.00
1.5
1.5
—
—
—
0
0
11
69
0.97
0.00
3.2
1.1
—
—
—
0
0
10
62
0.98
0.00
1.1
1.0
—
—
—
0
0
8
52
0.94
0.00
1.1
1.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.8
—
—
—
0
0
7
48
0.89
0.00
1.0
1.2
—
—
—
0
0
5
36
0.85
0.00
11.0
7.0
—
—
—
0
0
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
5
31
0.98
0.00
1.0
1.0
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: C3_MALE_GENITAL_EXALLC – malignant neoplasm of male genital organs, excluding all cancers (controls excluding all cancers)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).